PKCD
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A5A3E0 | S1068 | Sugiyama | POTEF A26C1B | SLSTFQQMWISKQEyDEsGPsIVHRKCL_____________ |
| A6NMY6 | S26 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | EILCKLsLEGDHstPPsAyGsVKAytNFDAERDALNIEtAI |
| O00165 | S210 | SIGNOR|PSP | HAX1 HS1BP1 | QVsQEGLGPVLQPQPKSYFKsISVTKITKPDGIVEERRTVV |
| O00429 | S616 | SIGNOR|PSP | DNM1L DLP1 DRP1 | SKAEELLAEEKsKPIPIMPAsPQKGHAVNLLDVPVPVARKL |
| O14939 | T566 | SIGNOR|PSP | PLD2 | VVHGLPARDLARHFIQRWNFtKTTKAKYKTPTYPYLLPKST |
| O15162 | T161 | SIGNOR|iPTMNet | PLSCR1 | FAAEDTDCCTRNCCGPSRPFtLRIIDNMGQEVITLERPLRC |
| O15350 | S289 | GPS6|SIGNOR|PSP | TP73 P73 | RPILIIITLEMRDGQVLGRRsFEGRICACPGRDRKADEDHY |
| O60814 | S39 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| O60841 | S222 | Sugiyama | EIF5B IF2 KIAA0741 | KNQKNKPGPNIEsGNEDDDAsFKIKTVAQKKAEKKERERKK |
| O76090 | S358 | SIGNOR|PSP | BEST1 VMD2 | WNKPEPQPPYTAASAQFRRAsFMGSTFNISLNKEEMEFQPN |
| O95544 | S46 | PSP | NADK | CHGDETWSYNHPIRGRAKsRsLsAsPALGsTKEFRRtRsLH |
| O95544 | S64 | PSP | NADK | sRsLsAsPALGsTKEFRRtRsLHGPCPVTTFGPKACVLQNP |
| O95817 | S187 | SIGNOR|PSP | BAG3 BIS | GPERsQsPAAsDCsssSsSAsLPssGRssLGsHQLPRGyIS |
| P00533 | T678 | SIGNOR|iPTMNet|PSP | EGFR ERBB ERBB1 HER1 | LVVALGIGLFMRRRHIVRKRtLRRLLQERELVEPLtPsGEA |
| P02545 | S22 | PSP | LMNA LMN1 | ETPsQRRAtRsGAQAsstPLsPtRItRLQEKEDLQELNDRL |
| P04040 | S167 | SIGNOR|PSP | CAT | GNNTPIFFIRDPILFPSFIHsQKRNPQTHLKDPDMVWDFWS |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | S46 | Sugiyama | ALDOA ALDA | PGKGILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtA |
| P04406 | S241 | PSP | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04406 | T246 | PSP | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKVVKQAS |
| P04637 | S46 | SIGNOR|PSP | TP53 P53 | LPENNVLsPLPsQAMDDLMLsPDDIEQWFtEDPGPDEAPRM |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05107 | S745 | GPS6|SIGNOR|ELM|PSP | ITGB2 CD18 MFI7 | ALIHLSDLREyRRFEKEKLKsQWNNDNPLFKsAtttVMNPK |
| P05107 | T758 | GPS6|SIGNOR|ELM|PSP | ITGB2 CD18 MFI7 | FEKEKLKsQWNNDNPLFKsAtttVMNPKFAES_________ |
| P05198 | S52 | SIGNOR|iPTMNet | EIF2S1 EIF2A | AYVSLLEYNNIEGMILLsELsRRRIRSINKLIRIGRNECVV |
| P05230 | S131 | PSP | FGF1 FGFA | TYISKKHAEKNWFVGLKKNGsCKRGPRTHYGQKAILFLPLP |
| P05787 | S74 | GPS6|SIGNOR|ELM|PSP | KRT8 CYK8 | YGGASGMGGITAVtVNQSLLsPLVLEVDPNIQAVRTQEKEQ |
| P06401 | S400 | PSP | PGR NR3C3 | FQPPALKIKEEEEGAEASARsPRSYLVAGANPAAFPDFPLG |
| P07108 | T42 | SIGNOR | DBI | DEEMLFIyGHyKQAtVGDINtERPGMLDFTGKAKWDAWNEL |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07355 | S26 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | EILCKLsLEGDHstPPsAyGsVKAytNFDAERDALNIEtAI |
| P07550 | S261 | SIGNOR|iPTMNet | ADRB2 ADRB2R B2AR | HVQNLsQVEQDGRTGHGLRRssKFCLKEHKALKTLGIIMGT |
| P07550 | S262 | SIGNOR|iPTMNet | ADRB2 ADRB2R B2AR | VQNLsQVEQDGRTGHGLRRssKFCLKEHKALKTLGIIMGTF |
| P07550 | S345 | SIGNOR|iPTMNet | ADRB2 ADRB2R B2AR | IyCRSPDFRIAFQELLCLRRssLKAyGNGyssNGNtGEQsG |
| P07550 | S346 | SIGNOR|iPTMNet | ADRB2 ADRB2R B2AR | yCRSPDFRIAFQELLCLRRssLKAyGNGyssNGNtGEQsGY |
| P08581 | S985 | GPS6|ELM|PSP | MET | GsELVRYDARVHtPHLDRLVsARsVsPttEMVsNEsVDyRA |
| P08913 | S247 | SIGNOR|iPTMNet | ADRA2A ADRA2R ADRAR | MILVYVRIYQIAKRRTRVPPsRRGPDAVAAPPGGTERRPNG |
| P09001 | Y265 | Sugiyama | MRPL3 MRL3 RPML3 | TGDIGRVWPGTKMPGKMGNIyRTEYGLKVWRINTKHNIIYV |
| P09758 | S322 | SIGNOR|PSP | TACSTD2 GA733-1 M1S1 TROP2 | KsGKYKKVEIKELGELRKEPsL___________________ |
| P0CG38 | S1068 | Sugiyama | POTEI | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG39 | S1031 | Sugiyama | POTEJ | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P10415 | S70 | PSP | BCL2 | SSQPGHtPHPAASRDPVARtsPLQtPAAPGAAAGPALsPVP |
| P10588 | S83 | SIGNOR|PSP | NR2F6 EAR2 ERBAL2 | SSGKHYGVFTCEGCKSFFKRsIRRNLSYTCRSNRDCQIDQH |
| P11413 | S180 | SIGNOR | G6PD | sQIGWNRIIVEKPFGRDLQSsDRLsNHIssLFREDQIYRID |
| P11413 | T236 | SIGNOR | G6PD | FANRIFGPIWNRDNIACVILtFKEPFGTEGRGGyFDEFGII |
| P12830 | T790 | SIGNOR|PSP | CDH1 CDHE UVO | sQLHRGLDARPEVTRNDVAPtLMsVPRyLPRPANPDEIGNF |
| P12931 | S12 | SIGNOR|PSP | SRC SRC1 | _________MGSNKSKPKDAsQRRRsLEPAENVHGAGGGAF |
| P13498 | T147 | SIGNOR|PSP | CYBA | RGEQWTPIEPKPRERPQIGGtIKQPPsNPPPRPPAEARKKP |
| P13796 | S5 | PSP | LCP1 PLS2 | ________________MARGsVsDEEMMELREAFAKVDtDG |
| P14314 | S126 | Sugiyama | PRKCSH G19P1 | yNsGVICENtCKEKGRKEREsLQQMAEVtREGFRLKKILIE |
| P14598 | S303 | GPS6|SIGNOR|PSP | NCF1 NOXO2 SH3PXD1A | sGQDVsQAQRQIKRGAPPRRssIRNAHsIHQRsRKRLsQDA |
| P14598 | S304 | GPS6|SIGNOR|PSP | NCF1 NOXO2 SH3PXD1A | GQDVsQAQRQIKRGAPPRRssIRNAHsIHQRsRKRLsQDAY |
| P14598 | S315 | GPS6|SIGNOR|PSP | NCF1 NOXO2 SH3PXD1A | KRGAPPRRssIRNAHsIHQRsRKRLsQDAYRRNsVRFLQQR |
| P14598 | S320 | GPS6|SIGNOR|PSP | NCF1 NOXO2 SH3PXD1A | PRRssIRNAHsIHQRsRKRLsQDAYRRNsVRFLQQRRRQAR |
| P14598 | S328 | GPS6|SIGNOR|PSP | NCF1 NOXO2 SH3PXD1A | AHsIHQRsRKRLsQDAYRRNsVRFLQQRRRQARPGPQsPGs |
| P14598 | S348 | SIGNOR|PSP | NCF1 NOXO2 SH3PXD1A | sVRFLQQRRRQARPGPQsPGsPLEEERQtQRsKPQPAVPPR |
| P14598 | S359 | GPS6|SIGNOR|PSP | NCF1 NOXO2 SH3PXD1A | ARPGPQsPGsPLEEERQtQRsKPQPAVPPRPsADLILNRCs |
| P14598 | S370 | GPS6|SIGNOR|PSP | NCF1 NOXO2 SH3PXD1A | LEEERQtQRsKPQPAVPPRPsADLILNRCsESTKRKLASAV |
| P14598 | S379 | GPS6|SIGNOR|PSP | NCF1 NOXO2 SH3PXD1A | sKPQPAVPPRPsADLILNRCsESTKRKLASAV_________ |
| P15407 | T217 | PSP | FOSL1 FRA1 | RPVPCISLSPGPVLEPEALHtPTLMTtPSLtPFtPSLVFTY |
| P15407 | T227 | PSP | FOSL1 FRA1 | GPVLEPEALHtPTLMTtPSLtPFtPSLVFTYPStPEPCASA |
| P15941 | T1224 | GPS6|SIGNOR|ELM|PSP | MUC1 PUM | HPMsEyPtyHtHGRyVPPsstDRsPyEKVsAGNGGssLsyt |
| P15941 | T224 | iPTMNet | MUC1 PUM | TRPAPGSTAPPAHGVTSAPDtRPAPGSTAPPAHGVTSAPDT |
| P17096 | S44 | SIGNOR | HMGA1 HMGIY | RGRGRPRKQPPVsPGtALVGsQKEPsEVPtPKRPRGRPKGs |
| P17096 | S64 | SIGNOR | HMGA1 HMGIY | sQKEPsEVPtPKRPRGRPKGsKNKGAAKTRKTTTtPGRKPR |
| P17405 | S510 | SIGNOR|PSP | SMPD1 ASM | YIGLNPGYRVYQIDGNYSGSsHVVLDHETYILNLTQANIPG |
| P18433 | S189 | SIGNOR | PTPRA PTPA PTPRL2 | IIVLYMLRFKKYKQAGSHSNsFRLSNGRtEDVEPQsVPLLA |
| P18433 | S204 | iPTMNet | PTPRA PTPA PTPRL2 | GSHSNsFRLSNGRtEDVEPQsVPLLARsPstNRKYPPLPVD |
| P18433 | S213 | SIGNOR | PTPRA PTPA PTPRL2 | SNGRtEDVEPQsVPLLARsPstNRKYPPLPVDKLEEEINRR |
| P19086 | S16 | iPTMNet | GNAZ | _____MGCRQSSEEKEAARRsRRIDRHLRSEsQRQRREIKL |
| P19086 | S27 | SIGNOR|iPTMNet | GNAZ | SEEKEAARRsRRIDRHLRSEsQRQRREIKLLLLGTSNSGKS |
| P19429 | S23 | SIGNOR|PSP | TNNI3 TNNC1 | DGSSDAAREPRPAPAPIRRRssNyRAYAtEPHAKKKsKIsA |
| P19429 | S24 | SIGNOR|PSP | TNNI3 TNNC1 | GSSDAAREPRPAPAPIRRRssNyRAYAtEPHAKKKsKIsAs |
| P19429 | T143 | SIGNOR|PSP | TNNI3 TNNC1 | TEIADLtQKIFDLRGKFKRPtLRRVRIsADAMMQALLGARA |
| P19634 | S648 | PSP | SLC9A1 APNH1 NHE1 | EEEIRKILRNNLQKTRQRLRsyNRHtLVADPyEEAWNQMLL |
| P21730 | S334 | SIGNOR|PSP | C5AR1 C5AR C5R1 | sLPsLLRNVLTEEsVVREsKsFTRsTVDTMAQKTQAV____ |
| P23246 | S283 | Sugiyama | SFPQ PSF | GPGGRsEEKIsDsEGFKANLsLLRRPGEKTyTQRCRLFVGN |
| P23396 | S6 | SIGNOR|PSP | RPS3 OK/SW-cl.26 | _______________MAVQIsKKRKFVADGIFKAELNEFLt |
| P23396 | T221 | SIGNOR|PSP | RPS3 OK/SW-cl.26 | KKPLPDHVsIVEPKDEILPttPIsEQKGGKPEPPAMPQPVP |
| P25098 | S29 | SIGNOR|iPTMNet | GRK2 ADRBK1 BARK BARK1 | ADVSyLMAMEKSKATPAARAsKKILLPEPSIRSVMQKYLED |
| P26010 | T783 | SIGNOR|iPTMNet | ITGB7 | KEQQQLNWKQDsNPLYKSAItttINPRFQEADSPTL_____ |
| P26373 | S181 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | YKKEKARVItEEEKNFKAFAsLRMARANARLFGIRAKRAKE |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P27797 | S52 | Sugiyama | CALR CRTC | GWtsRWIEsKHKSDFGKFVLssGKFyGDEEKDKGLQTSQDA |
| P28329 | S558 | SIGNOR | CHAT | ALQLAFYRLHRRLVPTYESAsIRRFQEGRVDNIRSAtPEAL |
| P28329 | S594 | SIGNOR | CHAT | tPEALAFVRAVTDHKAAVPAsEKLLLLKDAIRAQTAYTVMA |
| P29353 | S139 | SIGNOR | SHC1 SHC SHCA | GRRTRVEGGQLGGEEWTRHGsFVNKPTRGWLHPNDKVMGPG |
| P29353 | S28 | SIGNOR | SHC1 SHC SHCA | PKYNPLRNESLSSLEEGASGsTPPEELPsPSASSLGPILPP |
| P29474 | T495 | SIGNOR | NOS3 | YQPDPWKGSAAKGTGITRKKtFKEVANAVKISASLMGTVMA |
| P29692 | S44 | Sugiyama | EEF1D EF1D | RFyEQMNGPVAGAsRQENGAsVILRDIARARENIQKsLAGs |
| P29966 | S159 | SIGNOR | MARCKS MACS PRKCSL | EDGAtPsPsNEtPKKKKKRFsFKKsFKLsGFsFKKNKKEAG |
| P29966 | S163 | SIGNOR | MARCKS MACS PRKCSL | tPsPsNEtPKKKKKRFsFKKsFKLsGFsFKKNKKEAGEGGE |
| P29966 | S170 | SIGNOR | MARCKS MACS PRKCSL | tPKKKKKRFsFKKsFKLsGFsFKKNKKEAGEGGEAEAPAAE |
| P30086 | S153 | GPS6|SIGNOR|ELM|iPTMNet|PSP | PEBP1 PBP PEBP | CDEPILsNRsGDHRGKFKVAsFRKKyELRAPVAGtCyQAEW |
| P30273 | S69 | PSP | FCER1G | QVRKAAITSyEKsDGVytGLsTRNQEtyEtLKHEKPPQ___ |
| P30411 | S373 | SIGNOR|iPTMNet | BDKRB2 BKR2 | KGGCRSEPIQMENsMGTLRTsIsVERQIHKLQDWAGSRQ__ |
| P31431 | S179 | SIGNOR|iPTMNet | SDC4 | LFAVFLILLLMYRMKKKDEGsyDLGKKPIYKKAPTNEFyA_ |
| P31946 | S60 | GPS6|SIGNOR|ELM | YWHAB | NEERNLLsVAyKNVVGARRSsWRVIsSIEQKTERNEKKQQM |
| P35222 | S715 | SIGNOR|PSP | CTNNB1 CTNNB OK/SW-cl.35 PRO2286 | DLGLDIGAQGEPLGYRQDDPsyRsFHSGGYGQDALGMDPMM |
| P35236 | S246 | SIGNOR | PTPN7 | KECPEYTVRQLTIQYQEERRsVKHILFSAWPDHQTPESAGP |
| P35568 | S1101 | SIGNOR|iPTMNet | IRS1 | RNQSAKVIRADPQGCRRRHssEtFsstPSATRVGNTVPFGA |
| P35568 | S307 | GPS6|ELM|PSP | IRS1 | HHLNNPPPSQVGLTRRsRtEsItAtsPAsMVGGKPGsFRVR |
| P35568 | S323 | SIGNOR|PSP | IRS1 | sRtEsItAtsPAsMVGGKPGsFRVRAssDGEGtMsRPAsVD |
| P35568 | S441 | PSP | IRS1 | SDGGFISSDEYGSSPCDFRSsFRsVtPDsLGHtPPARGEEE |
| P35568 | S574 | GPS6|ELM|PSP | IRS1 | MMPAYPPGGGSGGRLPGHRHsAFVPTRSYPEEGLEMHPLER |
| P35568 | S616 | SIGNOR | IRS1 | GGHHRPDsstLHtDDGyMPMsPGVAPVPSGRKGsGDyMPMs |
| P35611 | S726 | PSP | ADD1 ADDA | GsDGSPGKSPsKKKKKFRtPsFLKKSKKKSDS_________ |
| P35612 | S713 | SIGNOR|iPTMNet | ADD2 ADDB | sPEGsPsKsPsKKKKKFRTPsFLKKSKKKEKVEs_______ |
| P35612 | S726 | SIGNOR|iPTMNet | ADD2 ADDB | KKKFRTPsFLKKSKKKEKVEs____________________ |
| P37837 | S13 | Sugiyama | TALDO1 TAL TALDO TALDOR | ________MsssPVKRQRMEsALDQLKQFTTVVADTGDFHA |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P40189 | T890 | GPS6|SIGNOR|ELM|iPTMNet|PSP | IL6ST | EVSAADAFGPGTEGQVERFEtVGMEAATDEGMPKSyLPQtV |
| P40189 | T909 | SIGNOR|iPTMNet | IL6ST | EtVGMEAATDEGMPKSyLPQtVRQGGyMPQ___________ |
| P40763 | S727 | GPS6|SIGNOR|ELM|PSP | STAT3 APRF | KTKFICVtPttCsNtIDLPMsPRTLDSLMQFGNNGEGAEPS |
| P41143 | S344 | SIGNOR|iPTMNet | OPRD1 OPRD | NFKRCFRQLCRKPCGRPDPSsFSRAREATARERVtACtPsD |
| P41594 | S840 | SIGNOR|iPTMNet | GRM5 GPRC1E MGLUR5 | PKVYIILAKPERNVRSAFTTstVVRMHVGDGKSSSAASRSS |
| P41594 | T841 | SIGNOR | GRM5 GPRC1E MGLUR5 | KVYIILAKPERNVRSAFTTstVVRMHVGDGKSSSAASRSSS |
| P42224 | S727 | SIGNOR|PSP | STAT1 | IsVsEVHPSRLQttDNLLPMsPEEFDEVSRIVGsVEFDSMM |
| P46060 | S24 | Sugiyama | RANGAP1 KIAA1835 SD | EDIAKLAETLAKTQVAGGQLsFKGKSLKLNTAEDAKDVIKE |
| P46776 | S68 | Sugiyama | RPL27A | yHPGyFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRV |
| P46777 | S176 | Sugiyama | RPL5 MSTP030 | GNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNAEVHR |
| P46777 | S224 | Sugiyama | RPL5 MSTP030 | VADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAH |
| P47712 | S727 | Sugiyama | PLA2G4A CPLA2 PLA2G4 | VIKEAMVESIEyRRQNPsRCsVsLsNVEARRFFNKEFLSKP |
| P48048 | S183 | iPTMNet | KCNJ1 ROMK1 | QSILGVIINSFMCGAILAKIsRPKKRAKtItFSKNAVIsKR |
| P48050 | T53 | GPS6|ELM | KCNJ4 IRK3 | ANLSNKSQRYMADIFTTCVDtRWRYMLMIFSAAFLVSWLFF |
| P49815 | S932 | SIGNOR|PSP | TSC2 TSC4 | ITKGLRSNVLLsFDDtPEKDsFRARsTsLNERPKSLRIARP |
| P49815 | S939 | SIGNOR|PSP | TSC2 TSC4 | NVLLsFDDtPEKDsFRARsTsLNERPKSLRIARPPKQGLNN |
| P49840 | S21 | SIGNOR|iPTMNet|PSP | GSK3A | MsGGGPsGGGPGGsGRARtssFAEPGGGGGGGGGGPGGsAs |
| P49841 | S9 | PSP | GSK3B | ____________MSGRPRttsFAEsCKPVQQPsAFGsMKVS |
| P51398 | S185 | PSP | DAP3 MRPS29 | CRDLLQSSYNKQRFDQPLEAstWLKNFKTTNERFLNQIKVQ |
| P51398 | S280 | PSP | DAP3 MRPS29 | VAVDGINALWGRTTLKREDKsPIAPEELALVHNLRKMMKND |
| P51398 | S31 | PSP | DAP3 MRPS29 | SRIHKLDPGRFLHMGTQARQsIAAHLDNQVPVEsPRAISRT |
| P51398 | T186 | PSP | DAP3 MRPS29 | RDLLQSSYNKQRFDQPLEAstWLKNFKTTNERFLNQIKVQE |
| P51398 | T237 | SIGNOR|PSP | DAP3 MRPS29 | EKGsPLGEVVEQGITRVRNAtDAVGIVLKELKRQssLGMFH |
| P52757 | S171 | SIGNOR|PSP | CHN2 ARHGAP3 BCH | PIyEHIGYATLLREKVsRRLsRsKNEPRKTNVTHEEHTAVE |
| P53004 | S21 | SIGNOR|PSP | BLVRA BLVR BVR | MNAEPERKFGVVVVGVGRAGsVRMRDLRNPHPsSAFLNLIG |
| P53004 | S230 | PSP | BLVRA BLVR BVR | KsPLSWIEEKGPGLKRNRyLsFHFKsGsLENVPNVGVNKNI |
| P53004 | S237 | SIGNOR|PSP | BLVRA BLVR BVR | EEKGPGLKRNRyLsFHFKsGsLENVPNVGVNKNIFLKDQNI |
| P53004 | S33 | SIGNOR|PSP | BLVRA BLVR BVR | VVGVGRAGsVRMRDLRNPHPsSAFLNLIGFVSRRELGSIDG |
| P53396 | S455 | Sugiyama | ACLY | ANFLLNAsGststPAPsRtAsFsEsRADEVAPAKKAKPAMP |
| P53396 | S656 | Sugiyama | ACLY | IGNTGGMLDNILASKLyRPGsVAyVSRsGGMsNELNNIISR |
| P53671 | S283 | GPS6|SIGNOR|ELM|PSP | LIMK2 | PHALSTLDTKENLEGtLRRRsLRRsNsIsKsPGPssPKEPL |
| P57053 | S39 | Sugiyama | H2BC12L H2BFS H2BS1 | VTKAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| P58753 | Y106 | PSP | TIRAP MAL | yDVCVCHSEEDLVAAQDLVSyLEGSTASLRCFLQLRDATPG |
| P58876 | S39 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| P60709 | S323 | Sugiyama | ACTB | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P60709 | S368 | Sugiyama | ACTB | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P61073 | S324 | SIGNOR|PSP | CXCR4 | FLGAKFKtsAQHALtsVsRGssLKILsKGKRGGHssVstEs |
| P61073 | S325 | SIGNOR|PSP | CXCR4 | LGAKFKtsAQHALtsVsRGssLKILsKGKRGGHssVstEsE |
| P61073 | S338 | SIGNOR | CXCR4 | tsVsRGssLKILsKGKRGGHssVstEsEsssFHss______ |
| P61073 | S339 | SIGNOR | CXCR4 | sVsRGssLKILsKGKRGGHssVstEsEsssFHss_______ |
| P61254 | S9 | Sugiyama | RPL26 | ____________MKFNPFVtsDRsKNRKRHFNAPsHIRRKI |
| P61254 | T8 | Sugiyama | RPL26 | _____________MKFNPFVtsDRsKNRKRHFNAPsHIRRK |
| P61513 | S21 | Sugiyama | RPL37A | MAKRTKKVGIVGKyGtRYGAsLRKMVKKIEISQHAKYTCSF |
| P61513 | Y14 | Sugiyama | RPL37A | _______MAKRTKKVGIVGKyGtRYGAsLRKMVKKIEISQH |
| P61927 | S50 | Sugiyama | RPL37 | QKSTCGKCGYPAKRKRKYNWsAKAKRRNTTGTGRMRHLKIV |
| P61978 | S284 | GPS6|ELM | HNRNPK HNRPK | MPPGRGGRPMPPSRRDyDDMsPRRGPPPPPPGRGGRGGsRA |
| P61978 | S302 | GPS6|SIGNOR|ELM|iPTMNet|PSP | HNRNPK HNRPK | DMsPRRGPPPPPPGRGGRGGsRARNLPLPPPPPPRGGDLMA |
| P62263 | S139 | Sugiyama | RPS14 PRO2640 | LARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL________ |
| P62280 | T15 | Sugiyama | RPS11 | ______MADIQTERAyQKQPtIFQNKKRVLLGEtGKEKLPR |
| P62736 | S325 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P62753 | S235 | PSP | RPS6 OK/SW-cl.2 | KRMKEAKEKRQEQIAKRRRLssLRAstsKsEssQK______ |
| P62753 | S236 | PSP | RPS6 OK/SW-cl.2 | RMKEAKEKRQEQIAKRRRLssLRAstsKsEssQK_______ |
| P62807 | S39 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | VTKAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIssKA |
| P62899 | T26 | Sugiyama | RPL31 | KGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRAPRAL |
| P62906 | T9 | Sugiyama | RPL10A NEDD6 | ____________MSSKVsRDtLyEAVREVLHGNQRKRRKFL |
| P62917 | S130 | Sugiyama | RPL8 | GTIVCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKL |
| P62917 | T135 | Sugiyama | RPL8 | CLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSK |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P63104 | S58 | SIGNOR|iPTMNet | YWHAZ | NEERNLLsVAyKNVVGARRssWRVVssIEQKTEGAEKKQQM |
| P63261 | S323 | Sugiyama | ACTG1 ACTG | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P63261 | S368 | Sugiyama | ACTG1 ACTG | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P63267 | S324 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P67809 | S136 | Sugiyama | YBX1 NSEP1 YB1 | GEKGAEAANVtGPGGVPVQGsKYAADRNHYRRYPRRRGPPR |
| P68032 | S325 | Sugiyama | ACTC1 ACTC | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68104 | T432 | SIGNOR|iPTMNet|Sugiyama | EEF1A1 EEF1A EF1A LENG7 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| P68133 | S325 | Sugiyama | ACTA1 ACTA | TTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68431 | T46 | SIGNOR|Sugiyama | H3C1 H3FA HIST1H3A; H3C2 H3FL HIST1H3B; H3C3 H3FC HIST1H3C; H3C4 H3FB HIST1H3D; H3C6 H3FD HIST1H3E; H3C7 H3FI HIST1H3F; H3C8 H3FH HIST1H3G; H3C10 H3FK HIST1H3H; H3C11 H3FF HIST1H3I; H3C12 H3FJ HIST1H3J | ARKsAPATGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| P78536 | T735 | PSP | ADAM17 CSVP TACE | MLSSMDSASVRIIKPFPAPQtPGRLQPAPVIPSAPAAPKLD |
| P84243 | T46 | Sugiyama | H3-3A H3.3A H3F3 H3F3A PP781; H3-3B H3.3B H3F3B | ARKsAPsTGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| P98082 | S24 | SIGNOR|iPTMNet|PSP | DAB2 DOC2 | EVEtSATNGQPDQQAAPKAPsKKEKKKGPEKTDEyLLARFK |
| Q00535 | T77 | SIGNOR|PSP | CDK5 CDKN5 PSSALRE | ELKHKNIVRLHDVLHSDKKLtLVFEFCDQDLKKYFDSCNGD |
| Q01543 | T312 | GPS6|SIGNOR|PSP | FLI1 | SDSANASCITWEGTNGEFKMtDPDEVARRWGERKSKPNMNY |
| Q01995 | S181 | SIGNOR|iPTMNet | TAGLN SM22 WS3-10 | REFtEsQLQEGKHVIGLQMGsNRGAsQAGMTGYGRPRQIIS |
| Q05639 | T432 | Sugiyama | EEF1A2 EEF1AL STN | VESFSQYPPLGRFAVRDMRQtVAVGVIKNVEKKSGGAGKVT |
| Q05655 | S215 | Sugiyama | PRKCD PKCD | AIHKKCIDKIIGRCTGTAANsRDtIFQKERFNIDMPHRFKV |
| Q05655 | S299 | GPS6|SIGNOR|EPSD|PSP|Sugiyama | PRKCD PKCD | LCGINQKLLAEALNQVtQRAsRRsDsAssEPVGIyQGFEKK |
| Q05655 | S302 | GPS6|SIGNOR|EPSD|PSP | PRKCD PKCD | INQKLLAEALNQVtQRAsRRsDsAssEPVGIyQGFEKKTGV |
| Q05655 | S304 | GPS6|SIGNOR|EPSD|PSP|Sugiyama | PRKCD PKCD | QKLLAEALNQVtQRAsRRsDsAssEPVGIyQGFEKKTGVAG |
| Q05655 | S307 | Sugiyama | PRKCD PKCD | LAEALNQVtQRAsRRsDsAssEPVGIyQGFEKKTGVAGEDM |
| Q05655 | S331 | Sugiyama | PRKCD PKCD | GIyQGFEKKTGVAGEDMQDNsGtyGKIWEGSsKCNINNFIF |
| Q05655 | S503 | GPS6|SIGNOR|PSP | PRKCD PKCD | RDGHIKIADFGMCKENIFGEsRAstFCGtPDyIAPEILQGL |
| Q05655 | S631 | Sugiyama | PRKCD PKCD | LEKRRLEPPFRPKVKsPRDysNFDQEFLNEKARLsysDKNL |
| Q05655 | S645 | SIGNOR|iPTMNet|PSP | PRKCD PKCD | KsPRDysNFDQEFLNEKARLsysDKNLIDsMDQsAFAGFsF |
| Q05655 | T141 | GPS6|SIGNOR|PSP | PRKCD PKCD | FLEDVDCKQsMRSEDEAKFPtMNRRGAIKQAKIHyIKNHEF |
| Q05655 | T218 | GPS6|SIGNOR|PSP|Sugiyama | PRKCD PKCD | KKCIDKIIGRCTGTAANsRDtIFQKERFNIDMPHRFKVHNY |
| Q05655 | T295 | GPS6|SIGNOR|PSP|Sugiyama | PRKCD PKCD | KVANLCGINQKLLAEALNQVtQRAsRRsDsAssEPVGIyQG |
| Q05655 | T333 | Sugiyama | PRKCD PKCD | yQGFEKKTGVAGEDMQDNsGtyGKIWEGSsKCNINNFIFHK |
| Q05655 | T507 | SIGNOR | PRKCD PKCD | IKIADFGMCKENIFGEsRAstFCGtPDyIAPEILQGLKyTF |
| Q05655 | T58 | Sugiyama | PRKCD PKCD | TERGKTLVQKKPTMyPEWKStFDAHIyEGRVIQIVLMRAAE |
| Q09472 | S89 | GPS6|SIGNOR|ELM|iPTMNet|PSP | EP300 P300 | GMVQDAASKHKQLSELLRsGssPNLNMGVGGPGQVMAsQAQ |
| Q12965 | T935 | Sugiyama | MYO1E MYO1C | VLQVSIGPGLPKNSRPTRRNttQNtGySsGtQNANyPVRAA |
| Q12965 | Y941 | Sugiyama | MYO1E MYO1C | GPGLPKNSRPTRRNttQNtGySsGtQNANyPVRAAPPPPGy |
| Q13263 | S473 | SIGNOR | TRIM28 KAP1 RNF96 TIF1B | sGDDPyssAEPHVsGVKRsRsGEGEVsGLMRKVPRVsLERL |
| Q13501 | S349 | PSP | SQSTM1 ORCA OSIL | DNCsGGDDDWtHLssKEVDPstGELQsLQMPEsEGPssLDP |
| Q13887 | S153 | SIGNOR|iPTMNet | KLF5 BTEB2 CKLF IKLF | SINMNVFLPDITHLRTGLYKsQRPCVTHIKTEPVAIFSHQS |
| Q14247 | S405 | SIGNOR|PSP | CTTN EMS1 | EEARRKLEEQARAKtQtPPVsPAPQPtEERLPssPVyEDAA |
| Q14247 | S418 | SIGNOR | CTTN EMS1 | KtQtPPVsPAPQPtEERLPssPVyEDAAsFKAELsyRGPVs |
| Q14432 | T311 | Sugiyama | PDE3A | RsssVVsAEMSGCSSKSHRRtsLPCIPREQLMGHSEWDHKR |
| Q14896 | S275 | SIGNOR | MYBPC3 | TVHEAMGTGDLDLLSAFRRTsLAGGGRRIsDSHEDTGILDF |
| Q14896 | S284 | SIGNOR | MYBPC3 | DLDLLSAFRRTsLAGGGRRIsDSHEDTGILDFSSLLKKRDs |
| Q14896 | S304 | SIGNOR | MYBPC3 | sDSHEDTGILDFSSLLKKRDsFRTPRDsKLEAPAEEDVWEI |
| Q15080 | S315 | PSP | NCF4 SH3PXD4 | VRLLSDEDVALMVRQARGLPsQKRLFPWKLHITQKDNYRVY |
| Q15080 | T154 | SIGNOR|iPTMNet|PSP | NCF4 SH3PXD4 | YQSPYDSEQVPQALRRLRPRtRKVKsVsPQGNsVDRMAAPR |
| Q15139 | S412 | PSP | PRKD1 PKD PKD1 PRKCM | ANRtIsPstsNNIPLMRVVQsVKHTKRKSsTVMKEGWMVHy |
| Q15139 | S738 | GPS6|SIGNOR|ELM|PSP | PRKD1 PKD PKD1 PRKCM | DPFPQVKLCDFGFARIIGEKsFRRsVVGtPAyLAPEVLRNK |
| Q15139 | S742 | GPS6|SIGNOR|ELM|PSP | PRKD1 PKD PKD1 PRKCM | QVKLCDFGFARIIGEKsFRRsVVGtPAyLAPEVLRNKGYNR |
| Q15185 | S72 | Sugiyama | PTGES3 P23 TEBP | EIDLFHCIDPNDsKHKRtDRsILCCLRKGEsGQsWPRLTKE |
| Q15438 | S394 | SIGNOR|iPTMNet | CYTH1 D17S811E PSCD1 | AAISRDPFYEMLAARKKKVSstKRH________________ |
| Q15438 | T395 | SIGNOR|iPTMNet | CYTH1 D17S811E PSCD1 | AISRDPFYEMLAARKKKVSstKRH_________________ |
| Q15717 | S221 | SIGNOR|PSP | ELAVL1 HUR | HsPARRFGGPVHHQAQRFRFsPMGVDHMSGLSGVNVPGNAS |
| Q15717 | S318 | SIGNOR|PSP | ELAVL1 HUR | AAMAIAsLNGYRLGDKILQVsFKTNKSHK____________ |
| Q16206 | S504 | SIGNOR|PSP | ENOX2 COVA1 | KLKDDKLQVEKMLENLKEKEsCASRLCASNQDSEYPLEKTM |
| Q16236 | S40 | SIGNOR|iPTMNet|PSP | NFE2L2 NRF2 | IDILWRQDIDLGVSREVFDFsQRRKEYELEKQKKLEKERQE |
| Q16658 | S39 | SIGNOR|iPTMNet | FSCN1 FAN1 HSN SNL | CGNKyLTAEAFGFKVNASAssLKKKQIWTLEQPPDEAGSAA |
| Q16695 | T46 | Sugiyama | H3-4 H3FT HIST3H3 | ARKsAPATGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| Q16820 | S687 | SIGNOR|iPTMNet | MEP1B | MLIITLVSVYCTRKKYRERMsSNRPNLTPQNQHAF______ |
| Q5JVS0 | T354 | SIGNOR|iPTMNet | HABP4 | MVKDDYEDDSHVFRKPANDItSQLEINFGNLPRPGRGARGG |
| Q5JVS0 | T375 | SIGNOR|iPTMNet | HABP4 | SQLEINFGNLPRPGRGARGGtRGGRGRIRRAENYGPRAEVV |
| Q5QNW6 | S39 | Sugiyama | H2BC18 HIST2H2BF | VTKVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q5VTE0 | T432 | Sugiyama | EEF1A1P5 EEF1AL3 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| Q6NXT2 | T45 | Sugiyama | H3-5 H3F3C | AARKSTPSTCGVKPHRyRPGtVALREIRRYQKstELLIRKL |
| Q6S8J3 | S1068 | Sugiyama | POTEE A26C1A POTE2 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q71DI3 | T46 | Sugiyama | H3C15 HIST2H3A; H3C14 H3F2 H3FM HIST2H3C; H3C13 HIST2H3D | ARKsAPATGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| Q7KZI7 | T596 | GPS6|PSP | MARK2 EMK1 | sssGGAPDRTNFPRGVssRstFHAGQLRQVRDQQNLPyGVt |
| Q86VQ1 | S223 | Sugiyama | GLCCI1 | QTPsCWAEEGAEKRSHQRsAsWGsADQLKEQIAKLRQQLQR |
| Q8IV61 | T133 | PSP | RASGRP3 GRP3 KIAA0846 | KHVSLIDISSIPSYDWMRRVtQRKKVSKKGKACLLFDHLEP |
| Q8IWX8 | S904 | Sugiyama | CHERP DAN26 SCAF6 | KGVGVALDDPyENyRRNKsysFIARMKARDECK________ |
| Q8IXH6 | S208 | Sugiyama | TP53INP2 C20orf110 DOR PINH | AVQRQNRARESRPRRSKNQSsFIyQPCQRQFNY________ |
| Q8IZ21 | S590 | Sugiyama | PHACTR4 PRO2963 | SKEEWNEIRHQIGNTLIRRLsQRPtPEELEQRNILQPKNEA |
| Q8N6T7 | T294 | GPS6 | SIRT6 SIR2L6 | PAWDGPRVLERALPPLPRPPtPKLEPKEEsPtRINGSIPAG |
| Q8NE86 | S92 | PSP | MCU C10orf42 CCDC109A | SDDVTVVYQNGLPVISVRLPsRRERCQFTLKPISDSVGVFL |
| Q8TCJ0 | S178 | SIGNOR|PSP | FBXO25 FBX25 | KVLDDHHNPRLIKDLLQDLSsTLCILIRGVGKSVLVGNINI |
| Q8TCU6 | S313 | PSP | PREX1 KIAA1415 | LFDNLLVYCKRKSRVTGSKKsTKRTKsINGSLYIFRGRINT |
| Q92793 | S437 | SIGNOR|iPTMNet | CREBBP CBP | SHWKNCTRHDCPVCLPLKNAsDKRNQQTILGSPASGIQNTI |
| Q92890 | S299 | Sugiyama | UFD1 UFD1L | KKVEEDEAGGRFVAFsGEGQsLRKKGRKP____________ |
| Q93079 | S39 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q96A00 | T38 | PSP | PPP1R14A CPI17 PPP1INL | SRARGPGGsPGGLQKRHARVtVKYDRRELQRRLDVEKWIDG |
| Q96C90 | T57 | SIGNOR|PSP | PPP1R14B PLCB3N PNG | AGEGPGGADDEGPVRRQGKVtVKYDRKELRKRLNLEEWILE |
| Q96D96 | S97 | GPS6|PSP | HVCN1 VSOP UNQ578/PRO1140 | APGPAPRAPLDFRGMLRKLFsSHRFQVIIICLVVLDALLVL |
| Q96D96 | T10 | SIGNOR | HVCN1 VSOP UNQ578/PRO1140 | ___________MATWDEKAVtRRAKVAPAERMSKFLRHFtV |
| Q96D96 | T29 | GPS6|PSP | HVCN1 VSOP UNQ578/PRO1140 | VtRRAKVAPAERMSKFLRHFtVVGDDYHAWNINYKKWENEE |
| Q99808 | S281 | SIGNOR|PSP | SLC29A1 ENT1 | AGKEEsGVsVsNsQPTNESHsIKAILKNISVLAFSVCFIFT |
| Q99848 | S270 | Sugiyama | EBNA1BP2 EBP2 | FGGKKKGSKWNtREsyDDVssFRAKTAHGRGLKRPGKKGSN |
| Q99877 | S39 | Sugiyama | H2BC15 H2BFD HIST1H2BN | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q99879 | S39 | Sugiyama | H2BC14 H2BFE HIST1H2BM | INKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q99880 | S39 | Sugiyama | H2BC13 H2BFC HIST1H2BL | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q9BYX7 | S368 | Sugiyama | POTEKP ACTBL3 FKSG30 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q9BZK7 | S123 | SIGNOR|PSP | TBL1XR1 IRA1 TBLR1 | LAQQQAAAAAAAAAAAsQQGsAKNGENTANGEENGAHTIAN |
| Q9H257 | T231 | PSP | CARD9 | DQLKHSLMKAEDDCKVERKHtLKLRHAMEQRPSQELLWELQ |
| Q9HBA0 | S162 | PSP | TRPV4 VRL2 VROAC | PPPILKVFNRPILFDIVSRGsTADLDGLLPFLLtHKKRLTD |
| Q9HBA0 | S189 | PSP | TRPV4 VRL2 VROAC | LLPFLLtHKKRLTDEEFREPsTGKTCLPKALLNLSNGRNDT |
| Q9HBA0 | T175 | PSP | TRPV4 VRL2 VROAC | FDIVSRGsTADLDGLLPFLLtHKKRLTDEEFREPsTGKTCL |
| Q9NQ66 | S887 | iPTMNet | PLCB1 KIAA0581 | TTTLTPKPPSQALHSQPAPGsVKAPAKTEDLIQSVLTEVEA |
| Q9NRY6 | T21 | SIGNOR|PSP | PLSCR3 | MAGYLPPKGYAPSPPPPYPVtPGYPEPALHPGPGQAPVPAQ |
| Q9UBP9 | T35 | GPS6 | GULP1 CED6 GULP | HTPEALSKHFIPYNAKFLGStEVEQPKGTEVVRDAVRKLKF |
| Q9UBS0 | S473 | GPS6|SIGNOR|ELM|PSP | RPS6KB2 STK14B | PPPPSTTAPLPIRPPSGTKKsKRGRGRPGR___________ |
| Q9UGV2 | S333 | Sugiyama | NDRG3 | MGYIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQsD |
| Q9UII2 | S39 | Sugiyama | ATP5IF1 ATPI ATPIF1 | TMQARGFGsDQSENVDRGAGsIREAGGAFGKREQAEEERyF |
| Q9UNX3 | S9 | Sugiyama | RPL26L1 RPL26P1 | ____________MKFNPFVtsDRsKNRKRHFNAPSHVRRKI |
| Q9UNX3 | T8 | Sugiyama | RPL26L1 RPL26P1 | _____________MKFNPFVtsDRsKNRKRHFNAPSHVRRK |
| Q9UQ13 | S297 | SIGNOR|PSP | SHOC2 KIAA0862 | PDTIGNLSSLSRLGLRYNRLsAIPRSLAKCSALEELNLENN |
| Q9UQ13 | T71 | SIGNOR|PSP | SHOC2 KIAA0862 | KDGKKDSSAAQPGVAFSVDNtIKRPNPAPGTRKKSSNAEVI |
| Q9UQ80 | S360 | GPS6|SIGNOR|PSP | PA2G4 EBP1 | PDLyKsEMEVQDAELKALLQssAsRKtQKKKKKKAsKtAEN |
| Q9UQL6 | S259 | SIGNOR|PSP | HDAC5 KIAA0600 | KLPLPGPYDSRDDFPLRKTAsEPNLKVRSRLKQKVAERRss |
| Q9UQL6 | S498 | SIGNOR | HDAC5 KIAA0600 | ATSMRTVGKLPRHRPLSRtQssPLPQSPQALQQLVMQQQHQ |
| Q9Y2R2 | S35 | GPS6|SIGNOR|PSP | PTPN22 PTPN8 | QSKKITKEEFANEFLKLKRQsTKYKADKTYPTTVAEKPKNI |
| Q9Y6H6 | S82 | SIGNOR | KCNE3 | LFVMFLFAVTVGSLILGYTRsRKVDKRSDPYHVYIKNRVSM |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Signal Transduction | R-HSA-162582 | 4.012679e-12 | 11.397 | 1 | 0 |
| Cell Cycle | R-HSA-1640170 | 6.080039e-10 | 9.216 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 4.711026e-09 | 8.327 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 8.067359e-09 | 8.093 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.321781e-08 | 7.879 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 3.244873e-08 | 7.489 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 5.314450e-08 | 7.275 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 5.966491e-08 | 7.224 | 1 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 6.444783e-08 | 7.191 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 7.934368e-07 | 6.100 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.367188e-06 | 5.864 | 1 | 1 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.682597e-06 | 5.774 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.125843e-06 | 5.672 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.125843e-06 | 5.672 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.358017e-06 | 5.627 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 4.080614e-06 | 5.389 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 4.830962e-06 | 5.316 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 5.095416e-06 | 5.293 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 5.791909e-06 | 5.237 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 5.887429e-06 | 5.230 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 7.110990e-06 | 5.148 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 9.881345e-06 | 5.005 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.060166e-05 | 4.975 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.124477e-05 | 4.949 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.306283e-05 | 4.884 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.281249e-05 | 4.892 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.277219e-05 | 4.894 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.292755e-05 | 4.888 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.503988e-05 | 4.823 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.788889e-05 | 4.747 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 2.711066e-05 | 4.567 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 3.300740e-05 | 4.481 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 5.052919e-05 | 4.296 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 5.392960e-05 | 4.268 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 5.955657e-05 | 4.225 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 6.890225e-05 | 4.162 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 6.956467e-05 | 4.158 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 7.688071e-05 | 4.114 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 8.619669e-05 | 4.065 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 8.619669e-05 | 4.065 | 0 | 0 |
| Kinesins | R-HSA-983189 | 8.961730e-05 | 4.048 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.021339e-04 | 3.991 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.203879e-04 | 3.919 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 1.372294e-04 | 3.863 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.480426e-04 | 3.830 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.975108e-04 | 3.704 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 2.138567e-04 | 3.670 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 2.189014e-04 | 3.660 | 1 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 2.401284e-04 | 3.620 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 3.055648e-04 | 3.515 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 3.308533e-04 | 3.480 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 3.296603e-04 | 3.482 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 3.358008e-04 | 3.474 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 3.955701e-04 | 3.403 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 4.069981e-04 | 3.390 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 4.227547e-04 | 3.374 | 1 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 4.386070e-04 | 3.358 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 4.405532e-04 | 3.356 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 4.674108e-04 | 3.330 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 4.564698e-04 | 3.341 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 4.700898e-04 | 3.328 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 4.900989e-04 | 3.310 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 5.346670e-04 | 3.272 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 5.689565e-04 | 3.245 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 6.281866e-04 | 3.202 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 6.647706e-04 | 3.177 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 6.882076e-04 | 3.162 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 6.701379e-04 | 3.174 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 7.242645e-04 | 3.140 | 1 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 8.098732e-04 | 3.092 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 7.926586e-04 | 3.101 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 7.926586e-04 | 3.101 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 8.818577e-04 | 3.055 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 8.926786e-04 | 3.049 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 8.678020e-04 | 3.062 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 9.318284e-04 | 3.031 | 1 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 9.956055e-04 | 3.002 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.000245e-03 | 3.000 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 1.015079e-03 | 2.994 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.064712e-03 | 2.973 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.199919e-03 | 2.921 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.199919e-03 | 2.921 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.199919e-03 | 2.921 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.183288e-03 | 2.927 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.199919e-03 | 2.921 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.146460e-03 | 2.941 | 1 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 1.288812e-03 | 2.890 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.331682e-03 | 2.876 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.331682e-03 | 2.876 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 1.337532e-03 | 2.874 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 1.722187e-03 | 2.764 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.660394e-03 | 2.780 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.699187e-03 | 2.770 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.660394e-03 | 2.780 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 1.771149e-03 | 2.752 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.772810e-03 | 2.751 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.935801e-03 | 2.713 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 2.087382e-03 | 2.680 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 2.075614e-03 | 2.683 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 2.175633e-03 | 2.662 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 2.175633e-03 | 2.662 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 2.205417e-03 | 2.657 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 2.206176e-03 | 2.656 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 2.280114e-03 | 2.642 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 2.475116e-03 | 2.606 | 1 | 0 |
| Deubiquitination | R-HSA-5688426 | 2.346740e-03 | 2.630 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 2.566087e-03 | 2.591 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 2.570559e-03 | 2.590 | 1 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 2.583549e-03 | 2.588 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 2.654316e-03 | 2.576 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 2.807293e-03 | 2.552 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 2.978176e-03 | 2.526 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 2.820714e-03 | 2.550 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 2.858083e-03 | 2.544 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 2.967888e-03 | 2.528 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 3.053337e-03 | 2.515 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 3.094954e-03 | 2.509 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 3.148922e-03 | 2.502 | 1 | 0 |
| Gap junction assembly | R-HSA-190861 | 3.223596e-03 | 2.492 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 3.233732e-03 | 2.490 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 3.292906e-03 | 2.482 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 3.362593e-03 | 2.473 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 3.421439e-03 | 2.466 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 3.836575e-03 | 2.416 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 3.671296e-03 | 2.435 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 3.930793e-03 | 2.406 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 3.957891e-03 | 2.403 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 3.967479e-03 | 2.401 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 4.343218e-03 | 2.362 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 4.504281e-03 | 2.346 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 4.845139e-03 | 2.315 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 4.773357e-03 | 2.321 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 4.639431e-03 | 2.334 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 4.930118e-03 | 2.307 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 4.989918e-03 | 2.302 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 5.198580e-03 | 2.284 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 5.372107e-03 | 2.270 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 5.372107e-03 | 2.270 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 5.522504e-03 | 2.258 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 5.522504e-03 | 2.258 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 5.958599e-03 | 2.225 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 5.958599e-03 | 2.225 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 6.564306e-03 | 2.183 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 6.256955e-03 | 2.204 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 6.537187e-03 | 2.185 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 6.654992e-03 | 2.177 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 6.482584e-03 | 2.188 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 6.677418e-03 | 2.175 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 6.845410e-03 | 2.165 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 6.879062e-03 | 2.162 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 6.897722e-03 | 2.161 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 6.924630e-03 | 2.160 | 1 | 0 |
| Ephrin signaling | R-HSA-3928664 | 7.196015e-03 | 2.143 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 7.261277e-03 | 2.139 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 7.532480e-03 | 2.123 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 8.451454e-03 | 2.073 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 7.957520e-03 | 2.099 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 8.451454e-03 | 2.073 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 7.934221e-03 | 2.100 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 8.114369e-03 | 2.091 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 8.451454e-03 | 2.073 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 8.024778e-03 | 2.096 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 8.280995e-03 | 2.082 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 8.750006e-03 | 2.058 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 8.796391e-03 | 2.056 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 9.917124e-03 | 2.004 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 9.917124e-03 | 2.004 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 9.917124e-03 | 2.004 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.003896e-02 | 1.998 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 1.003896e-02 | 1.998 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.003896e-02 | 1.998 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 1.067502e-02 | 1.972 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.080567e-02 | 1.966 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 1.143573e-02 | 1.942 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.092514e-02 | 1.962 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 1.080567e-02 | 1.966 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 1.187972e-02 | 1.925 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 1.189166e-02 | 1.925 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 1.189166e-02 | 1.925 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 1.189166e-02 | 1.925 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.276860e-02 | 1.894 | 1 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.297396e-02 | 1.887 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 1.299370e-02 | 1.886 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.299370e-02 | 1.886 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.397089e-02 | 1.855 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.445783e-02 | 1.840 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 1.471164e-02 | 1.832 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.495246e-02 | 1.825 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.739595e-02 | 1.760 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 1.718116e-02 | 1.765 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 1.600264e-02 | 1.796 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.596684e-02 | 1.797 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 1.551131e-02 | 1.809 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.625853e-02 | 1.789 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.642870e-02 | 1.784 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 1.573133e-02 | 1.803 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.598962e-02 | 1.796 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.761913e-02 | 1.754 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.767970e-02 | 1.753 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 1.836731e-02 | 1.736 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 1.836731e-02 | 1.736 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 1.836731e-02 | 1.736 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 1.852045e-02 | 1.732 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.860293e-02 | 1.730 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.872835e-02 | 1.728 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.890546e-02 | 1.723 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 2.016062e-02 | 1.695 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 2.061588e-02 | 1.686 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 2.061588e-02 | 1.686 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 2.065622e-02 | 1.685 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 2.100723e-02 | 1.678 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 2.107172e-02 | 1.676 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 2.107172e-02 | 1.676 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 2.160759e-02 | 1.665 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 2.223790e-02 | 1.653 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 2.310464e-02 | 1.636 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 2.548879e-02 | 1.594 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 2.412693e-02 | 1.617 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 2.524526e-02 | 1.598 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 2.524526e-02 | 1.598 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 2.379802e-02 | 1.623 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 2.498670e-02 | 1.602 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 2.435444e-02 | 1.613 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 2.456543e-02 | 1.610 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 2.456543e-02 | 1.610 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 2.420287e-02 | 1.616 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 2.621971e-02 | 1.581 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 2.710577e-02 | 1.567 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 2.711473e-02 | 1.567 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 2.856832e-02 | 1.544 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 2.888425e-02 | 1.539 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 2.906829e-02 | 1.537 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 2.912125e-02 | 1.536 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 2.912779e-02 | 1.536 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 2.925257e-02 | 1.534 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 2.932762e-02 | 1.533 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 2.932762e-02 | 1.533 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 3.008577e-02 | 1.522 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 3.008577e-02 | 1.522 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 3.064997e-02 | 1.514 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 3.101639e-02 | 1.508 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 3.128485e-02 | 1.505 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 3.128485e-02 | 1.505 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 3.128485e-02 | 1.505 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 3.128485e-02 | 1.505 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 3.454373e-02 | 1.462 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 3.454373e-02 | 1.462 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 3.454373e-02 | 1.462 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 3.454373e-02 | 1.462 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 3.454373e-02 | 1.462 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 3.454373e-02 | 1.462 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 3.454373e-02 | 1.462 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 3.454373e-02 | 1.462 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 3.182540e-02 | 1.497 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 3.182540e-02 | 1.497 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 3.410011e-02 | 1.467 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 3.215020e-02 | 1.493 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 3.229179e-02 | 1.491 | 1 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 3.385732e-02 | 1.470 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 3.551778e-02 | 1.450 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 3.455489e-02 | 1.461 | 0 | 0 |
| Depurination | R-HSA-73927 | 3.385732e-02 | 1.470 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 3.673954e-02 | 1.435 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 3.410011e-02 | 1.467 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 3.695485e-02 | 1.432 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 3.718603e-02 | 1.430 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 3.886859e-02 | 1.410 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 3.892792e-02 | 1.410 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 3.916769e-02 | 1.407 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 3.916769e-02 | 1.407 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 3.916769e-02 | 1.407 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 3.925847e-02 | 1.406 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 3.948823e-02 | 1.404 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 3.968479e-02 | 1.401 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 3.968479e-02 | 1.401 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 3.970016e-02 | 1.401 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 4.080578e-02 | 1.389 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 4.227041e-02 | 1.374 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 4.227041e-02 | 1.374 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 4.235952e-02 | 1.373 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 4.235952e-02 | 1.373 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 4.235952e-02 | 1.373 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 4.276133e-02 | 1.369 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 4.276133e-02 | 1.369 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 4.276133e-02 | 1.369 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 4.276133e-02 | 1.369 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 4.276133e-02 | 1.369 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 4.296995e-02 | 1.367 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 4.296995e-02 | 1.367 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 4.304553e-02 | 1.366 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 4.316024e-02 | 1.365 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 4.436971e-02 | 1.353 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 4.473618e-02 | 1.349 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 4.483937e-02 | 1.348 | 0 | 0 |
| Protein folding | R-HSA-391251 | 4.536919e-02 | 1.343 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 4.544078e-02 | 1.343 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 4.610958e-02 | 1.336 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 4.622418e-02 | 1.335 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 4.699102e-02 | 1.328 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 4.735322e-02 | 1.325 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 4.910384e-02 | 1.309 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 5.756603e-02 | 1.240 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 5.756603e-02 | 1.240 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 5.756603e-02 | 1.240 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 5.895525e-02 | 1.229 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 5.197878e-02 | 1.284 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 4.925072e-02 | 1.308 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 5.895525e-02 | 1.229 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 5.781917e-02 | 1.238 | 1 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 5.476226e-02 | 1.262 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 5.039217e-02 | 1.298 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 4.994923e-02 | 1.301 | 1 | 0 |
| Dopamine receptors | R-HSA-390651 | 5.756603e-02 | 1.240 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 5.396628e-02 | 1.268 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 5.039217e-02 | 1.298 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 5.895525e-02 | 1.229 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 5.912011e-02 | 1.228 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 6.045785e-02 | 1.219 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 6.045785e-02 | 1.219 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 6.103292e-02 | 1.214 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 6.103292e-02 | 1.214 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 6.103292e-02 | 1.214 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 6.103292e-02 | 1.214 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 6.103292e-02 | 1.214 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 6.169606e-02 | 1.210 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 6.388467e-02 | 1.195 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 6.405185e-02 | 1.193 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 6.405185e-02 | 1.193 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 6.413930e-02 | 1.193 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 6.449606e-02 | 1.190 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 6.561080e-02 | 1.183 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 6.623460e-02 | 1.179 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 6.632613e-02 | 1.178 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 6.687927e-02 | 1.175 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 6.772291e-02 | 1.169 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 7.079690e-02 | 1.150 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 7.079690e-02 | 1.150 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 7.079690e-02 | 1.150 | 0 | 0 |
| Transport of glycerol from adipocytes to the liver by Aquaporins | R-HSA-432030 | 7.079690e-02 | 1.150 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 7.079690e-02 | 1.150 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 8.247915e-02 | 1.084 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 8.247915e-02 | 1.084 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 8.247915e-02 | 1.084 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 7.741131e-02 | 1.111 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 6.904782e-02 | 1.161 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 6.904782e-02 | 1.161 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 6.904782e-02 | 1.161 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 8.519166e-02 | 1.070 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 8.519166e-02 | 1.070 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 8.519166e-02 | 1.070 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 8.519166e-02 | 1.070 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 8.519166e-02 | 1.070 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 8.519166e-02 | 1.070 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 8.519166e-02 | 1.070 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 7.324378e-02 | 1.135 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 7.430022e-02 | 1.129 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 7.430022e-02 | 1.129 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 8.488494e-02 | 1.071 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 8.488494e-02 | 1.071 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 8.488494e-02 | 1.071 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 6.953595e-02 | 1.158 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 8.203493e-02 | 1.086 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 7.875343e-02 | 1.104 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 7.163130e-02 | 1.145 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 7.889370e-02 | 1.103 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 8.029947e-02 | 1.095 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 7.541126e-02 | 1.123 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 6.953595e-02 | 1.158 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 6.953595e-02 | 1.158 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 8.396323e-02 | 1.076 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 7.306645e-02 | 1.136 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 7.480422e-02 | 1.126 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 7.571149e-02 | 1.121 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 7.875343e-02 | 1.104 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 8.519166e-02 | 1.070 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 6.823683e-02 | 1.166 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 8.185752e-02 | 1.087 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 8.203493e-02 | 1.086 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 6.817985e-02 | 1.166 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 7.741131e-02 | 1.111 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 6.817985e-02 | 1.166 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 7.077938e-02 | 1.150 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 7.029195e-02 | 1.153 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 7.901265e-02 | 1.102 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 7.171420e-02 | 1.144 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 7.526720e-02 | 1.123 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 7.741131e-02 | 1.111 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 8.548138e-02 | 1.068 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 8.548138e-02 | 1.068 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 8.548138e-02 | 1.068 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 8.569318e-02 | 1.067 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 8.686673e-02 | 1.061 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 8.724844e-02 | 1.059 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 8.869064e-02 | 1.052 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 9.142229e-02 | 1.039 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 9.304581e-02 | 1.031 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 9.395428e-02 | 1.027 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 9.432297e-02 | 1.025 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 9.688465e-02 | 1.014 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 9.713741e-02 | 1.013 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 9.713741e-02 | 1.013 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 9.812168e-02 | 1.008 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 9.839635e-02 | 1.007 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 9.928818e-02 | 1.003 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.006765e-01 | 0.997 | 0 | 0 |
| Drug resistance of KIT mutants | R-HSA-9669937 | 1.346090e-01 | 0.871 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 1.346090e-01 | 0.871 | 0 | 0 |
| KIT mutants bind TKIs | R-HSA-9669921 | 1.346090e-01 | 0.871 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 1.346090e-01 | 0.871 | 0 | 0 |
| Regorafenib-resistant KIT mutants | R-HSA-9669929 | 1.346090e-01 | 0.871 | 0 | 0 |
| Sunitinib-resistant KIT mutants | R-HSA-9669934 | 1.346090e-01 | 0.871 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 1.346090e-01 | 0.871 | 0 | 0 |
| Imatinib-resistant KIT mutants | R-HSA-9669917 | 1.346090e-01 | 0.871 | 0 | 0 |
| Sorafenib-resistant KIT mutants | R-HSA-9669936 | 1.346090e-01 | 0.871 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 1.346090e-01 | 0.871 | 0 | 0 |
| Nilotinib-resistant KIT mutants | R-HSA-9669926 | 1.346090e-01 | 0.871 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 1.346090e-01 | 0.871 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 1.346090e-01 | 0.871 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.346090e-01 | 0.871 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p14ARF Defects | R-HSA-9646304 | 1.346090e-01 | 0.871 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 1.346090e-01 | 0.871 | 0 | 0 |
| Dasatinib-resistant KIT mutants | R-HSA-9669914 | 1.346090e-01 | 0.871 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 1.346090e-01 | 0.871 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p14ARF Defects | R-HSA-9646303 | 1.346090e-01 | 0.871 | 0 | 0 |
| Masitinib-resistant KIT mutants | R-HSA-9669924 | 1.346090e-01 | 0.871 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.346090e-01 | 0.871 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.147845e-01 | 0.940 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 1.147845e-01 | 0.940 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 1.147845e-01 | 0.940 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 1.147845e-01 | 0.940 | 0 | 0 |
| Diseases of cellular response to stress | R-HSA-9675132 | 1.147845e-01 | 0.940 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.147845e-01 | 0.940 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.147845e-01 | 0.940 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.147845e-01 | 0.940 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.147845e-01 | 0.940 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.147845e-01 | 0.940 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.147845e-01 | 0.940 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.147845e-01 | 0.940 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 1.147845e-01 | 0.940 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.147845e-01 | 0.940 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.147845e-01 | 0.940 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.147845e-01 | 0.940 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 1.111865e-01 | 0.954 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 1.111865e-01 | 0.954 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 1.111865e-01 | 0.954 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.217205e-01 | 0.915 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 1.217205e-01 | 0.915 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 1.217205e-01 | 0.915 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 1.217205e-01 | 0.915 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 1.031340e-01 | 0.987 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.030603e-01 | 0.987 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 1.200153e-01 | 0.921 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 1.200153e-01 | 0.921 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 1.155476e-01 | 0.937 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 1.155476e-01 | 0.937 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.107204e-01 | 0.956 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 1.014153e-01 | 0.994 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 1.030633e-01 | 0.987 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.102851e-01 | 0.957 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 1.033901e-01 | 0.986 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 1.280291e-01 | 0.893 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 1.314955e-01 | 0.881 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 1.200153e-01 | 0.921 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 1.342461e-01 | 0.872 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 1.217205e-01 | 0.915 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 1.103360e-01 | 0.957 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.031340e-01 | 0.987 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 1.040042e-01 | 0.983 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 1.111865e-01 | 0.954 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 1.258966e-01 | 0.900 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.155476e-01 | 0.937 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 1.099642e-01 | 0.959 | 1 | 0 |
| MTOR signalling | R-HSA-165159 | 1.151925e-01 | 0.939 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 1.251998e-01 | 0.902 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 1.251998e-01 | 0.902 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 1.185915e-01 | 0.926 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.087130e-01 | 0.964 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.102851e-01 | 0.957 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 1.291418e-01 | 0.889 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.118476e-01 | 0.951 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 1.200153e-01 | 0.921 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.046470e-01 | 0.980 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 1.200153e-01 | 0.921 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 1.155476e-01 | 0.937 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.127537e-01 | 0.948 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.217205e-01 | 0.915 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 1.185915e-01 | 0.926 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 1.322795e-01 | 0.879 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 1.200153e-01 | 0.921 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.054946e-01 | 0.977 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 1.227839e-01 | 0.911 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 1.217205e-01 | 0.915 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 1.314955e-01 | 0.881 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 1.211512e-01 | 0.917 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 1.355677e-01 | 0.868 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 1.382543e-01 | 0.859 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 1.382543e-01 | 0.859 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 1.388121e-01 | 0.858 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 1.388121e-01 | 0.858 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 1.391001e-01 | 0.857 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 1.394795e-01 | 0.855 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 1.394795e-01 | 0.855 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.429285e-01 | 0.845 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 1.431014e-01 | 0.844 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.439561e-01 | 0.842 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 1.439561e-01 | 0.842 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.440244e-01 | 0.842 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 1.440244e-01 | 0.842 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 1.440244e-01 | 0.842 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 1.440244e-01 | 0.842 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 1.452108e-01 | 0.838 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 1.466574e-01 | 0.834 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 1.471502e-01 | 0.832 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.471502e-01 | 0.832 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.471502e-01 | 0.832 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.471502e-01 | 0.832 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.471502e-01 | 0.832 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 1.484720e-01 | 0.828 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.484720e-01 | 0.828 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.484720e-01 | 0.828 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 2.156099e-01 | 0.666 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 2.156099e-01 | 0.666 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 2.156099e-01 | 0.666 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 2.156099e-01 | 0.666 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 2.156099e-01 | 0.666 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 2.156099e-01 | 0.666 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 2.156099e-01 | 0.666 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 2.156099e-01 | 0.666 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 1.776073e-01 | 0.751 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 1.776073e-01 | 0.751 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 1.776073e-01 | 0.751 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 1.776073e-01 | 0.751 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 1.776073e-01 | 0.751 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.776073e-01 | 0.751 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 1.776073e-01 | 0.751 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 2.140921e-01 | 0.669 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 2.140921e-01 | 0.669 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 2.140921e-01 | 0.669 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 2.140921e-01 | 0.669 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 2.140921e-01 | 0.669 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 2.140921e-01 | 0.669 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 1.744219e-01 | 0.758 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 1.744219e-01 | 0.758 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 1.667171e-01 | 0.778 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 1.667171e-01 | 0.778 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 1.667171e-01 | 0.778 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 2.032537e-01 | 0.692 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 2.032537e-01 | 0.692 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 2.032537e-01 | 0.692 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 2.032537e-01 | 0.692 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.576974e-01 | 0.802 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 1.907073e-01 | 0.720 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 1.720518e-01 | 0.764 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 2.222756e-01 | 0.653 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 2.253828e-01 | 0.647 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 2.076774e-01 | 0.683 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 1.650579e-01 | 0.782 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.910921e-01 | 0.719 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 2.019062e-01 | 0.695 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 2.274396e-01 | 0.643 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 2.062969e-01 | 0.686 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 2.034935e-01 | 0.691 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 1.720518e-01 | 0.764 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 1.666712e-01 | 0.778 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 2.222756e-01 | 0.653 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 1.576974e-01 | 0.802 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 2.089639e-01 | 0.680 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.862399e-01 | 0.730 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 2.186021e-01 | 0.660 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 2.032537e-01 | 0.692 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 1.907073e-01 | 0.720 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 1.778093e-01 | 0.750 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.664192e-01 | 0.779 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 1.687155e-01 | 0.773 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.922560e-01 | 0.716 | 1 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 2.217908e-01 | 0.654 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.895102e-01 | 0.722 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 1.786758e-01 | 0.748 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 2.253351e-01 | 0.647 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 2.253351e-01 | 0.647 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 1.895102e-01 | 0.722 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 2.156099e-01 | 0.666 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 2.158284e-01 | 0.666 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 2.222756e-01 | 0.653 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 2.264931e-01 | 0.645 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 1.667171e-01 | 0.778 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 1.667171e-01 | 0.778 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 2.140921e-01 | 0.669 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 1.667171e-01 | 0.778 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.667171e-01 | 0.778 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.661800e-01 | 0.779 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.600100e-01 | 0.796 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 2.032537e-01 | 0.692 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 2.151188e-01 | 0.667 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 2.056963e-01 | 0.687 | 1 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 1.637692e-01 | 0.786 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 2.156099e-01 | 0.666 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 1.975017e-01 | 0.704 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 1.630936e-01 | 0.788 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 1.630936e-01 | 0.788 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 2.076774e-01 | 0.683 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 2.128700e-01 | 0.672 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 1.895542e-01 | 0.722 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 1.931093e-01 | 0.714 | 1 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 1.895542e-01 | 0.722 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 1.896615e-01 | 0.722 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 1.934071e-01 | 0.714 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 1.756385e-01 | 0.755 | 1 | 1 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 1.762486e-01 | 0.754 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 2.032537e-01 | 0.692 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 1.760248e-01 | 0.754 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 1.756385e-01 | 0.755 | 1 | 0 |
| Pyroptosis | R-HSA-5620971 | 2.253828e-01 | 0.647 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 1.760248e-01 | 0.754 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 2.076774e-01 | 0.683 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 1.744219e-01 | 0.758 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 1.630987e-01 | 0.788 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 1.878917e-01 | 0.726 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 2.156099e-01 | 0.666 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 2.156099e-01 | 0.666 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 1.776073e-01 | 0.751 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 2.140921e-01 | 0.669 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.744219e-01 | 0.758 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.744219e-01 | 0.758 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 1.998153e-01 | 0.699 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.517049e-01 | 0.819 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 2.170910e-01 | 0.663 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 1.662950e-01 | 0.779 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 1.951653e-01 | 0.710 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 1.704950e-01 | 0.768 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 1.704950e-01 | 0.768 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 1.704950e-01 | 0.768 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 2.112876e-01 | 0.675 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.931093e-01 | 0.714 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 2.195395e-01 | 0.658 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 2.195395e-01 | 0.658 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 1.744219e-01 | 0.758 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 2.049516e-01 | 0.688 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 1.656212e-01 | 0.781 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 1.782521e-01 | 0.749 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 2.242072e-01 | 0.649 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 2.170910e-01 | 0.663 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.650579e-01 | 0.782 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 1.961340e-01 | 0.707 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 2.277086e-01 | 0.643 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 2.315922e-01 | 0.635 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 2.333559e-01 | 0.632 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 2.333559e-01 | 0.632 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 2.333559e-01 | 0.632 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 2.333559e-01 | 0.632 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 2.333559e-01 | 0.632 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 2.333559e-01 | 0.632 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 2.333559e-01 | 0.632 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 2.337621e-01 | 0.631 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 2.337621e-01 | 0.631 | 0 | 0 |
| Impaired BRCA2 translocation to the nucleus | R-HSA-9709275 | 2.511051e-01 | 0.600 | 0 | 0 |
| Impaired BRCA2 binding to SEM1 (DSS1) | R-HSA-9763198 | 2.511051e-01 | 0.600 | 0 | 0 |
| Defective Mismatch Repair Associated With PMS2 | R-HSA-5632987 | 2.511051e-01 | 0.600 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9632697 | 2.511051e-01 | 0.600 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function | R-HSA-9645722 | 2.511051e-01 | 0.600 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 2.511051e-01 | 0.600 | 0 | 0 |
| Defective Mismatch Repair Associated With MLH1 | R-HSA-5545483 | 2.511051e-01 | 0.600 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9630791 | 2.511051e-01 | 0.600 | 0 | 0 |
| PI and PC transport between ER and Golgi membranes | R-HSA-1483196 | 3.519247e-01 | 0.454 | 0 | 0 |
| Abasic sugar-phosphate removal via the single-nucleotide replacement pathway | R-HSA-73930 | 3.519247e-01 | 0.454 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 3.519247e-01 | 0.454 | 0 | 0 |
| Signaling by extracellular domain mutants of KIT | R-HSA-9680187 | 3.519247e-01 | 0.454 | 0 | 0 |
| Signaling by juxtamembrane domain KIT mutants | R-HSA-9669935 | 3.519247e-01 | 0.454 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 3.519247e-01 | 0.454 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 3.519247e-01 | 0.454 | 0 | 0 |
| NFG and proNGF binds to p75NTR | R-HSA-205017 | 3.519247e-01 | 0.454 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 3.519247e-01 | 0.454 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 3.519247e-01 | 0.454 | 0 | 0 |
| Defective CD320 causes MMATC | R-HSA-3359485 | 3.519247e-01 | 0.454 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 3.519247e-01 | 0.454 | 0 | 0 |
| Signaling by kinase domain mutants of KIT | R-HSA-9669933 | 3.519247e-01 | 0.454 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5660724 | 3.519247e-01 | 0.454 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 3.519247e-01 | 0.454 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 3.519247e-01 | 0.454 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5619081 | 3.519247e-01 | 0.454 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 3.519247e-01 | 0.454 | 0 | 0 |
| XAV939 stabilizes AXIN | R-HSA-5545619 | 3.519247e-01 | 0.454 | 0 | 0 |
| MPS IIID - Sanfilippo syndrome D | R-HSA-2206305 | 3.519247e-01 | 0.454 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 3.519247e-01 | 0.454 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 3.519247e-01 | 0.454 | 0 | 0 |
| Intestinal infectious diseases | R-HSA-8942233 | 3.519247e-01 | 0.454 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 3.519247e-01 | 0.454 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 2.686511e-01 | 0.571 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.686511e-01 | 0.571 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.686511e-01 | 0.571 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 2.686511e-01 | 0.571 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 2.519724e-01 | 0.599 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 2.519724e-01 | 0.599 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 2.519724e-01 | 0.599 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 2.519724e-01 | 0.599 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 2.519724e-01 | 0.599 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 3.216308e-01 | 0.493 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 3.216308e-01 | 0.493 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 3.216308e-01 | 0.493 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 3.216308e-01 | 0.493 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 3.216308e-01 | 0.493 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 3.216308e-01 | 0.493 | 0 | 0 |
| HHAT G278V doesn't palmitoylate Hh-Np | R-HSA-5658034 | 4.391766e-01 | 0.357 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 4.391766e-01 | 0.357 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 4.391766e-01 | 0.357 | 0 | 0 |
| Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum) | R-HSA-5655799 | 4.391766e-01 | 0.357 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 2.644391e-01 | 0.578 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 2.644391e-01 | 0.578 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 3.736049e-01 | 0.428 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 3.736049e-01 | 0.428 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 3.736049e-01 | 0.428 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 3.736049e-01 | 0.428 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 3.736049e-01 | 0.428 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 3.736049e-01 | 0.428 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 3.298142e-01 | 0.482 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 3.298142e-01 | 0.482 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 3.298142e-01 | 0.482 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 2.962217e-01 | 0.528 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 2.962217e-01 | 0.528 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 2.962217e-01 | 0.528 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 2.962217e-01 | 0.528 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 2.687655e-01 | 0.571 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 2.455161e-01 | 0.610 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 2.464792e-01 | 0.608 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 2.694159e-01 | 0.570 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 3.688601e-01 | 0.433 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 3.688601e-01 | 0.433 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 3.688601e-01 | 0.433 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 3.688601e-01 | 0.433 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 3.688601e-01 | 0.433 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 4.238842e-01 | 0.373 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 4.238842e-01 | 0.373 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 4.238842e-01 | 0.373 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 4.238842e-01 | 0.373 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 2.681529e-01 | 0.572 | 1 | 1 |
| Tight junction interactions | R-HSA-420029 | 2.938528e-01 | 0.532 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 3.241208e-01 | 0.489 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 3.608284e-01 | 0.443 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 3.608284e-01 | 0.443 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 4.074758e-01 | 0.390 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 3.522767e-01 | 0.453 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 3.522767e-01 | 0.453 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 3.522767e-01 | 0.453 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 3.128702e-01 | 0.505 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 2.558666e-01 | 0.592 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 2.771320e-01 | 0.557 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 3.069157e-01 | 0.513 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 3.931698e-01 | 0.405 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 4.719832e-01 | 0.326 | 0 | 0 |
| RSK activation | R-HSA-444257 | 4.719832e-01 | 0.326 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 4.719832e-01 | 0.326 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 4.719832e-01 | 0.326 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 2.724857e-01 | 0.565 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 3.009833e-01 | 0.521 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 3.691751e-01 | 0.433 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 3.691751e-01 | 0.433 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 4.453483e-01 | 0.351 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 4.252502e-01 | 0.371 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 4.252502e-01 | 0.371 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 3.945647e-01 | 0.404 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 3.945647e-01 | 0.404 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 3.820135e-01 | 0.418 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 3.820135e-01 | 0.418 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 4.367798e-01 | 0.360 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 4.367798e-01 | 0.360 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 4.367798e-01 | 0.360 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 4.568832e-01 | 0.340 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 4.284710e-01 | 0.368 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 4.451189e-01 | 0.352 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 4.500769e-01 | 0.347 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 4.503797e-01 | 0.346 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 4.556596e-01 | 0.341 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 4.284710e-01 | 0.368 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 4.073548e-01 | 0.390 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 3.945647e-01 | 0.404 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 4.199127e-01 | 0.377 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 3.820135e-01 | 0.418 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 2.687655e-01 | 0.571 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 3.357318e-01 | 0.474 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 3.603337e-01 | 0.443 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 3.706910e-01 | 0.431 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 3.706910e-01 | 0.431 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 3.205419e-01 | 0.494 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 4.453483e-01 | 0.351 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 4.138612e-01 | 0.383 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 4.515655e-01 | 0.345 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 3.043698e-01 | 0.517 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 3.688601e-01 | 0.433 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 3.616345e-01 | 0.442 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 4.648554e-01 | 0.333 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 4.681034e-01 | 0.330 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 4.353394e-01 | 0.361 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 4.458790e-01 | 0.351 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 2.596925e-01 | 0.586 | 1 | 1 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 2.413774e-01 | 0.617 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 2.907087e-01 | 0.537 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 3.688601e-01 | 0.433 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 4.568832e-01 | 0.340 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 3.283266e-01 | 0.484 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 4.192097e-01 | 0.378 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 2.443463e-01 | 0.612 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 2.694159e-01 | 0.570 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 3.320054e-01 | 0.479 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 3.187046e-01 | 0.497 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 4.074758e-01 | 0.390 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 2.419068e-01 | 0.616 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 4.451189e-01 | 0.352 | 0 | 0 |
| Formation of lateral plate mesoderm | R-HSA-9758920 | 3.216308e-01 | 0.493 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 4.238842e-01 | 0.373 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 3.357318e-01 | 0.474 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 3.326464e-01 | 0.478 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 3.776776e-01 | 0.423 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 3.187046e-01 | 0.497 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 2.458930e-01 | 0.609 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 3.357318e-01 | 0.474 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 4.353394e-01 | 0.361 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 4.719832e-01 | 0.326 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 3.241488e-01 | 0.489 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 2.686511e-01 | 0.571 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 2.419068e-01 | 0.616 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 3.608284e-01 | 0.443 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 3.608284e-01 | 0.443 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 4.074758e-01 | 0.390 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 3.813273e-01 | 0.419 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 4.387360e-01 | 0.358 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 2.817264e-01 | 0.550 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 3.805364e-01 | 0.420 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 2.743756e-01 | 0.562 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 4.592946e-01 | 0.338 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 2.549046e-01 | 0.594 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 3.963500e-01 | 0.402 | 0 | 0 |
| S Phase | R-HSA-69242 | 4.458765e-01 | 0.351 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 3.284353e-01 | 0.484 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 4.006452e-01 | 0.397 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 3.813273e-01 | 0.419 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 3.128702e-01 | 0.505 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 3.109682e-01 | 0.507 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 3.134507e-01 | 0.504 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 3.216308e-01 | 0.493 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 2.907087e-01 | 0.537 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 2.458930e-01 | 0.609 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 2.938528e-01 | 0.532 | 1 | 1 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 3.438510e-01 | 0.464 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 4.719832e-01 | 0.326 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 4.719832e-01 | 0.326 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 4.719832e-01 | 0.326 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 4.453483e-01 | 0.351 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 3.588088e-01 | 0.445 | 1 | 1 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 3.603337e-01 | 0.443 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 3.113388e-01 | 0.507 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 3.756619e-01 | 0.425 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 3.046310e-01 | 0.516 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 4.458790e-01 | 0.351 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 3.608284e-01 | 0.443 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 4.199127e-01 | 0.377 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 4.284710e-01 | 0.368 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 3.956201e-01 | 0.403 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 2.962217e-01 | 0.528 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 3.284353e-01 | 0.484 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 3.608284e-01 | 0.443 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 4.568832e-01 | 0.340 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 2.519724e-01 | 0.599 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 3.284353e-01 | 0.484 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 2.938528e-01 | 0.532 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 3.945647e-01 | 0.404 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 2.840007e-01 | 0.547 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 2.421824e-01 | 0.616 | 1 | 1 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 4.207084e-01 | 0.376 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 3.025901e-01 | 0.519 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 3.012845e-01 | 0.521 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 2.519724e-01 | 0.599 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 2.907087e-01 | 0.537 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 2.962217e-01 | 0.528 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 3.688601e-01 | 0.433 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 4.719832e-01 | 0.326 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 4.652062e-01 | 0.332 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 3.357318e-01 | 0.474 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 4.539823e-01 | 0.343 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 2.903135e-01 | 0.537 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 2.686511e-01 | 0.571 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 2.464792e-01 | 0.608 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 3.522767e-01 | 0.453 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 2.920462e-01 | 0.535 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 4.337729e-01 | 0.363 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 3.334712e-01 | 0.477 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 3.334712e-01 | 0.477 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 2.511051e-01 | 0.600 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 2.511051e-01 | 0.600 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 3.519247e-01 | 0.454 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 2.519724e-01 | 0.599 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 2.519724e-01 | 0.599 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 4.391766e-01 | 0.357 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 4.391766e-01 | 0.357 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 4.391766e-01 | 0.357 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 3.736049e-01 | 0.428 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.419068e-01 | 0.616 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 3.284353e-01 | 0.484 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 3.284353e-01 | 0.484 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 4.238842e-01 | 0.373 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 3.608284e-01 | 0.443 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 3.069157e-01 | 0.513 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 3.334712e-01 | 0.477 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 3.886776e-01 | 0.410 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 3.389605e-01 | 0.470 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 4.073776e-01 | 0.390 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 2.695105e-01 | 0.569 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 3.187046e-01 | 0.497 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 3.357318e-01 | 0.474 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 3.001662e-01 | 0.523 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 3.517430e-01 | 0.454 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 4.644981e-01 | 0.333 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 2.694159e-01 | 0.570 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 4.568832e-01 | 0.340 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 4.696003e-01 | 0.328 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 3.298142e-01 | 0.482 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 2.938528e-01 | 0.532 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 4.719832e-01 | 0.326 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 4.537723e-01 | 0.343 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 3.043698e-01 | 0.517 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 2.938528e-01 | 0.532 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 3.357318e-01 | 0.474 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 3.430997e-01 | 0.465 | 1 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 4.074758e-01 | 0.390 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 4.074758e-01 | 0.390 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 4.074758e-01 | 0.390 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 3.931698e-01 | 0.405 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 3.957462e-01 | 0.403 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 4.570669e-01 | 0.340 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 2.421824e-01 | 0.616 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 3.101129e-01 | 0.508 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 3.550833e-01 | 0.450 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 2.628105e-01 | 0.580 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 2.997933e-01 | 0.523 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 4.132847e-01 | 0.384 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 2.686511e-01 | 0.571 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 3.216308e-01 | 0.493 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 4.391766e-01 | 0.357 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 3.298142e-01 | 0.482 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 4.719832e-01 | 0.326 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 4.077468e-01 | 0.390 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 4.138612e-01 | 0.383 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 3.241208e-01 | 0.489 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 4.074758e-01 | 0.390 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 2.686511e-01 | 0.571 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 2.686511e-01 | 0.571 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 4.391766e-01 | 0.357 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 4.719832e-01 | 0.326 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 3.910346e-01 | 0.408 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 3.246989e-01 | 0.489 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 4.453483e-01 | 0.351 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 3.931698e-01 | 0.405 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 3.216308e-01 | 0.493 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 3.216308e-01 | 0.493 | 0 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 4.391766e-01 | 0.357 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 4.252502e-01 | 0.371 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 3.522194e-01 | 0.453 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 4.744726e-01 | 0.324 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 4.779169e-01 | 0.321 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 4.780613e-01 | 0.321 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 4.822191e-01 | 0.317 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 4.822191e-01 | 0.317 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 4.822191e-01 | 0.317 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 4.829598e-01 | 0.316 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 4.879056e-01 | 0.312 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 4.879056e-01 | 0.312 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 4.879056e-01 | 0.312 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 4.879056e-01 | 0.312 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 4.879056e-01 | 0.312 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 4.879056e-01 | 0.312 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 4.880952e-01 | 0.311 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 4.947400e-01 | 0.306 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 4.998522e-01 | 0.301 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 5.008789e-01 | 0.300 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 5.008789e-01 | 0.300 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 5.024253e-01 | 0.299 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 5.062645e-01 | 0.296 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 5.073558e-01 | 0.295 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of other transcription factors | R-HSA-8866906 | 5.146859e-01 | 0.288 | 0 | 0 |
| Activation of Na-permeable kainate receptors | R-HSA-451307 | 5.146859e-01 | 0.288 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 5.146859e-01 | 0.288 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 5.146859e-01 | 0.288 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 5.146859e-01 | 0.288 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 5.146859e-01 | 0.288 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 5.146859e-01 | 0.288 | 0 | 0 |
| Defective GCLC causes HAGGSD | R-HSA-5578999 | 5.146859e-01 | 0.288 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 5.146859e-01 | 0.288 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 5.146859e-01 | 0.288 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 5.146859e-01 | 0.288 | 0 | 0 |
| CASP5-mediated substrate cleavage | R-HSA-9960525 | 5.146859e-01 | 0.288 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 5.146859e-01 | 0.288 | 0 | 0 |
| CASP4-mediated substrate cleavage | R-HSA-9960519 | 5.146859e-01 | 0.288 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 5.146859e-01 | 0.288 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 5.146859e-01 | 0.288 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 5.175779e-01 | 0.286 | 1 | 1 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 5.175779e-01 | 0.286 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 5.175779e-01 | 0.286 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 5.175779e-01 | 0.286 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 5.175779e-01 | 0.286 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 5.175779e-01 | 0.286 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 5.175779e-01 | 0.286 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 5.175779e-01 | 0.286 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 5.175779e-01 | 0.286 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 5.175779e-01 | 0.286 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 5.175779e-01 | 0.286 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 5.178803e-01 | 0.286 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 5.178803e-01 | 0.286 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 5.178803e-01 | 0.286 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 5.178803e-01 | 0.286 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 5.178803e-01 | 0.286 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 5.178803e-01 | 0.286 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 5.178803e-01 | 0.286 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 5.181770e-01 | 0.286 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 5.181770e-01 | 0.286 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 5.181770e-01 | 0.286 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 5.181770e-01 | 0.286 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 5.181770e-01 | 0.286 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 5.181770e-01 | 0.286 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 5.181770e-01 | 0.286 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 5.181770e-01 | 0.286 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 5.185556e-01 | 0.285 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 5.185556e-01 | 0.285 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 5.185556e-01 | 0.285 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 5.189909e-01 | 0.285 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 5.194597e-01 | 0.284 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 5.194597e-01 | 0.284 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 5.194597e-01 | 0.284 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 5.199471e-01 | 0.284 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 5.209434e-01 | 0.283 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 5.284220e-01 | 0.277 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 5.386128e-01 | 0.269 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 5.386128e-01 | 0.269 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 5.404513e-01 | 0.267 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 5.414208e-01 | 0.266 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 5.427726e-01 | 0.265 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 5.447037e-01 | 0.264 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 5.447037e-01 | 0.264 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 5.447037e-01 | 0.264 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 5.475794e-01 | 0.262 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 5.475794e-01 | 0.262 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 5.475794e-01 | 0.262 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 5.475794e-01 | 0.262 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 5.475794e-01 | 0.262 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 5.521698e-01 | 0.258 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 5.521698e-01 | 0.258 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 5.521698e-01 | 0.258 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 5.521698e-01 | 0.258 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 5.525689e-01 | 0.258 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 5.542735e-01 | 0.256 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 5.587547e-01 | 0.253 | 1 | 1 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 5.604706e-01 | 0.251 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 5.604706e-01 | 0.251 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 5.604706e-01 | 0.251 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 5.604706e-01 | 0.251 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 5.604706e-01 | 0.251 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 5.604706e-01 | 0.251 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 5.604706e-01 | 0.251 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 5.604706e-01 | 0.251 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 5.604706e-01 | 0.251 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 5.604706e-01 | 0.251 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 5.608483e-01 | 0.251 | 1 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 5.631555e-01 | 0.249 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 5.660229e-01 | 0.247 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 5.660229e-01 | 0.247 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 5.660229e-01 | 0.247 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 5.660229e-01 | 0.247 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 5.701580e-01 | 0.244 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 5.704320e-01 | 0.244 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 5.730234e-01 | 0.242 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 5.750246e-01 | 0.240 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 5.751374e-01 | 0.240 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 5.760155e-01 | 0.240 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 5.760155e-01 | 0.240 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 5.760155e-01 | 0.240 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 5.760155e-01 | 0.240 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 5.760155e-01 | 0.240 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 5.760155e-01 | 0.240 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 5.760155e-01 | 0.240 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 5.774410e-01 | 0.238 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 5.800324e-01 | 0.237 | 0 | 0 |
| Nucleotide catabolism defects | R-HSA-9735786 | 5.800324e-01 | 0.237 | 0 | 0 |
| Defective PNP disrupts phosphorolysis of (deoxy)guanosine and (deoxy)inosine | R-HSA-9735763 | 5.800324e-01 | 0.237 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 5.800324e-01 | 0.237 | 0 | 0 |
| ATP sensitive Potassium channels | R-HSA-1296025 | 5.800324e-01 | 0.237 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 5.800324e-01 | 0.237 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 5.800324e-01 | 0.237 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 5.800324e-01 | 0.237 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 5.800324e-01 | 0.237 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 5.800324e-01 | 0.237 | 0 | 0 |
| Transmission across Electrical Synapses | R-HSA-112307 | 5.800324e-01 | 0.237 | 0 | 0 |
| Electric Transmission Across Gap Junctions | R-HSA-112303 | 5.800324e-01 | 0.237 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 5.800324e-01 | 0.237 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 5.803667e-01 | 0.236 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 5.803667e-01 | 0.236 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 5.806592e-01 | 0.236 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 5.849667e-01 | 0.233 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 5.849667e-01 | 0.233 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 5.849667e-01 | 0.233 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 5.849667e-01 | 0.233 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 5.849667e-01 | 0.233 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 5.849667e-01 | 0.233 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 5.853409e-01 | 0.233 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 5.861329e-01 | 0.232 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 5.948535e-01 | 0.226 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 5.948535e-01 | 0.226 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 5.948535e-01 | 0.226 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 5.948535e-01 | 0.226 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 5.948535e-01 | 0.226 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 5.948535e-01 | 0.226 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 5.957438e-01 | 0.225 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 6.004914e-01 | 0.221 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 6.005625e-01 | 0.221 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 6.005625e-01 | 0.221 | 0 | 0 |
| FGFR2b ligand binding and activation | R-HSA-190377 | 6.005625e-01 | 0.221 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 6.005625e-01 | 0.221 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 6.005625e-01 | 0.221 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 6.005625e-01 | 0.221 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 6.005625e-01 | 0.221 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 6.005625e-01 | 0.221 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 6.005625e-01 | 0.221 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 6.034078e-01 | 0.219 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 6.107203e-01 | 0.214 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 6.161867e-01 | 0.210 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 6.161867e-01 | 0.210 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 6.161867e-01 | 0.210 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 6.234821e-01 | 0.205 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 6.296510e-01 | 0.201 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 6.296972e-01 | 0.201 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 6.296972e-01 | 0.201 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 6.296972e-01 | 0.201 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 6.296972e-01 | 0.201 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 6.296972e-01 | 0.201 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 6.311771e-01 | 0.200 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 6.345726e-01 | 0.198 | 0 | 0 |
| Activation of AMPA receptors | R-HSA-399710 | 6.365834e-01 | 0.196 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 6.365834e-01 | 0.196 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 6.365834e-01 | 0.196 | 0 | 0 |
| Defective SLC1A3 causes episodic ataxia 6 (EA6) | R-HSA-5619062 | 6.365834e-01 | 0.196 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 6.365834e-01 | 0.196 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 6.365834e-01 | 0.196 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 6.365834e-01 | 0.196 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 6.365834e-01 | 0.196 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 6.365834e-01 | 0.196 | 0 | 0 |
| Trafficking of myristoylated proteins to the cilium | R-HSA-5624138 | 6.365834e-01 | 0.196 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 6.365834e-01 | 0.196 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 6.365834e-01 | 0.196 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 6.365834e-01 | 0.196 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 6.365834e-01 | 0.196 | 0 | 0 |
| Zinc efflux and compartmentalization by the SLC30 family | R-HSA-435368 | 6.365834e-01 | 0.196 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 6.365834e-01 | 0.196 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 6.378301e-01 | 0.195 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 6.378301e-01 | 0.195 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 6.378301e-01 | 0.195 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 6.378301e-01 | 0.195 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 6.378301e-01 | 0.195 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 6.378301e-01 | 0.195 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 6.457767e-01 | 0.190 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 6.457767e-01 | 0.190 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 6.457767e-01 | 0.190 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 6.457767e-01 | 0.190 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 6.457767e-01 | 0.190 | 0 | 0 |
| PKA activation | R-HSA-163615 | 6.457767e-01 | 0.190 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 6.457767e-01 | 0.190 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 6.457767e-01 | 0.190 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 6.457767e-01 | 0.190 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 6.457767e-01 | 0.190 | 0 | 0 |
| Immune System | R-HSA-168256 | 6.530536e-01 | 0.185 | 1 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 6.548408e-01 | 0.184 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 6.548408e-01 | 0.184 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 6.548408e-01 | 0.184 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 6.548707e-01 | 0.184 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 6.628451e-01 | 0.179 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 6.639050e-01 | 0.178 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 6.644259e-01 | 0.178 | 1 | 1 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 6.723070e-01 | 0.172 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 6.723070e-01 | 0.172 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 6.723070e-01 | 0.172 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 6.723070e-01 | 0.172 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 6.723070e-01 | 0.172 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 6.723070e-01 | 0.172 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 6.723070e-01 | 0.172 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 6.723070e-01 | 0.172 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 6.723070e-01 | 0.172 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 6.726696e-01 | 0.172 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 6.737108e-01 | 0.172 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 6.737108e-01 | 0.172 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 6.737108e-01 | 0.172 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 6.737108e-01 | 0.172 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 6.788110e-01 | 0.168 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 6.788110e-01 | 0.168 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 6.788110e-01 | 0.168 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 6.788110e-01 | 0.168 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 6.788110e-01 | 0.168 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 6.810202e-01 | 0.167 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 6.851341e-01 | 0.164 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 6.851341e-01 | 0.164 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 6.855223e-01 | 0.164 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 6.855223e-01 | 0.164 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 6.855223e-01 | 0.164 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 6.855223e-01 | 0.164 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 6.855223e-01 | 0.164 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 6.855223e-01 | 0.164 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 6.855223e-01 | 0.164 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 6.855223e-01 | 0.164 | 0 | 0 |
| Phase 1 - inactivation of fast Na+ channels | R-HSA-5576894 | 6.855223e-01 | 0.164 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 6.855223e-01 | 0.164 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 6.855223e-01 | 0.164 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 6.855223e-01 | 0.164 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 6.855223e-01 | 0.164 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 6.855223e-01 | 0.164 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 6.855223e-01 | 0.164 | 0 | 0 |
| Formation of the Editosome | R-HSA-75094 | 6.855223e-01 | 0.164 | 0 | 0 |
| Ceramide signalling | R-HSA-193681 | 6.855223e-01 | 0.164 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 6.855223e-01 | 0.164 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 6.855223e-01 | 0.164 | 0 | 0 |
| Acetylcholine inhibits contraction of outer hair cells | R-HSA-9667769 | 6.855223e-01 | 0.164 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 6.855223e-01 | 0.164 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 6.855223e-01 | 0.164 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 6.855223e-01 | 0.164 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 6.890458e-01 | 0.162 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 6.986310e-01 | 0.156 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 6.999859e-01 | 0.155 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 7.015932e-01 | 0.154 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 7.015932e-01 | 0.154 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 7.015932e-01 | 0.154 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 7.015932e-01 | 0.154 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 7.015932e-01 | 0.154 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 7.040689e-01 | 0.152 | 0 | 0 |
| FGFR2c ligand binding and activation | R-HSA-190375 | 7.040689e-01 | 0.152 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 7.040689e-01 | 0.152 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 7.040689e-01 | 0.152 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 7.040689e-01 | 0.152 | 0 | 0 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 7.040689e-01 | 0.152 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 7.040689e-01 | 0.152 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 7.040689e-01 | 0.152 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 7.040689e-01 | 0.152 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 7.040689e-01 | 0.152 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 7.054372e-01 | 0.152 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 7.054372e-01 | 0.152 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 7.061511e-01 | 0.151 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 7.082693e-01 | 0.150 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 7.102740e-01 | 0.149 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 7.102740e-01 | 0.149 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 7.102740e-01 | 0.149 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 7.102740e-01 | 0.149 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 7.102740e-01 | 0.149 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 7.109406e-01 | 0.148 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 7.118612e-01 | 0.148 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 7.140707e-01 | 0.146 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 7.155595e-01 | 0.145 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 7.218835e-01 | 0.142 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 7.231846e-01 | 0.141 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 7.231846e-01 | 0.141 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 7.231846e-01 | 0.141 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 7.231846e-01 | 0.141 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 7.231846e-01 | 0.141 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 7.240142e-01 | 0.140 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 7.246182e-01 | 0.140 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 7.246182e-01 | 0.140 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 7.246182e-01 | 0.140 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 7.246182e-01 | 0.140 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 7.246182e-01 | 0.140 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 7.246182e-01 | 0.140 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 7.254408e-01 | 0.139 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 7.254408e-01 | 0.139 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 7.278734e-01 | 0.138 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 7.278734e-01 | 0.138 | 0 | 0 |
| Highly sodium permeable postsynaptic acetylcholine nicotinic receptors | R-HSA-629587 | 7.278734e-01 | 0.138 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 7.278734e-01 | 0.138 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 7.278734e-01 | 0.138 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 7.278734e-01 | 0.138 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 7.278734e-01 | 0.138 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 7.278734e-01 | 0.138 | 0 | 0 |
| Intracellular metabolism of fatty acids regulates insulin secretion | R-HSA-434313 | 7.278734e-01 | 0.138 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 7.278734e-01 | 0.138 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 7.278734e-01 | 0.138 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 7.278734e-01 | 0.138 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 7.278734e-01 | 0.138 | 0 | 0 |
| Lipid particle organization | R-HSA-8964572 | 7.278734e-01 | 0.138 | 0 | 0 |
| Leukotriene receptors | R-HSA-391906 | 7.278734e-01 | 0.138 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 7.278734e-01 | 0.138 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 7.278734e-01 | 0.138 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 7.281791e-01 | 0.138 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 7.318345e-01 | 0.136 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 7.320060e-01 | 0.135 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 7.332217e-01 | 0.135 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 7.332217e-01 | 0.135 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 7.332217e-01 | 0.135 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 7.332217e-01 | 0.135 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 7.332217e-01 | 0.135 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 7.332217e-01 | 0.135 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 7.332217e-01 | 0.135 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 7.332217e-01 | 0.135 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 7.332217e-01 | 0.135 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 7.332217e-01 | 0.135 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 7.355927e-01 | 0.133 | 1 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 7.373963e-01 | 0.132 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 7.432440e-01 | 0.129 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 7.432440e-01 | 0.129 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 7.432440e-01 | 0.129 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 7.435927e-01 | 0.129 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 7.435927e-01 | 0.129 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 7.448115e-01 | 0.128 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 7.453418e-01 | 0.128 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 7.453418e-01 | 0.128 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 7.472779e-01 | 0.127 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 7.476390e-01 | 0.126 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 7.476390e-01 | 0.126 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 7.478474e-01 | 0.126 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 7.527037e-01 | 0.123 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 7.582199e-01 | 0.120 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 7.592777e-01 | 0.120 | 1 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 7.598921e-01 | 0.119 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 7.598921e-01 | 0.119 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 7.598921e-01 | 0.119 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 7.598921e-01 | 0.119 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 7.598921e-01 | 0.119 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 7.598921e-01 | 0.119 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 7.598921e-01 | 0.119 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 7.598921e-01 | 0.119 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 7.598921e-01 | 0.119 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 7.598921e-01 | 0.119 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 7.598921e-01 | 0.119 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 7.609261e-01 | 0.119 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 7.624141e-01 | 0.118 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 7.645231e-01 | 0.117 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 7.645231e-01 | 0.117 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 7.645231e-01 | 0.117 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 7.645231e-01 | 0.117 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 7.645231e-01 | 0.117 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 7.645231e-01 | 0.117 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 7.645231e-01 | 0.117 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 7.645231e-01 | 0.117 | 0 | 0 |
| FGFR3b ligand binding and activation | R-HSA-190371 | 7.645231e-01 | 0.117 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 7.645231e-01 | 0.117 | 0 | 0 |
| mRNA Editing: C to U Conversion | R-HSA-72200 | 7.645231e-01 | 0.117 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 7.645231e-01 | 0.117 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 7.645231e-01 | 0.117 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 7.645231e-01 | 0.117 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 7.645231e-01 | 0.117 | 0 | 0 |
| Glycoprotein hormones | R-HSA-209822 | 7.645231e-01 | 0.117 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 7.645231e-01 | 0.117 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 7.645231e-01 | 0.117 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 7.690923e-01 | 0.114 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 7.690923e-01 | 0.114 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 7.702747e-01 | 0.113 | 1 | 1 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 7.721568e-01 | 0.112 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 7.739718e-01 | 0.111 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 7.762079e-01 | 0.110 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 7.762780e-01 | 0.110 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 7.767221e-01 | 0.110 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 7.773471e-01 | 0.109 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 7.809304e-01 | 0.107 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 7.809304e-01 | 0.107 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 7.842197e-01 | 0.106 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 7.842197e-01 | 0.106 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 7.842197e-01 | 0.106 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 7.842197e-01 | 0.106 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 7.842197e-01 | 0.106 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 7.842197e-01 | 0.106 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 7.842197e-01 | 0.106 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 7.853303e-01 | 0.105 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 7.890319e-01 | 0.103 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 7.890319e-01 | 0.103 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 7.890319e-01 | 0.103 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 7.890319e-01 | 0.103 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 7.890319e-01 | 0.103 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 7.890319e-01 | 0.103 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 7.908764e-01 | 0.102 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 7.912882e-01 | 0.102 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 7.925118e-01 | 0.101 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 7.930407e-01 | 0.101 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 7.930407e-01 | 0.101 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 7.937155e-01 | 0.100 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 7.944061e-01 | 0.100 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 7.962387e-01 | 0.099 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 7.962387e-01 | 0.099 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 7.962387e-01 | 0.099 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 7.962387e-01 | 0.099 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 7.962387e-01 | 0.099 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 7.962387e-01 | 0.099 | 0 | 0 |
| Highly calcium permeable nicotinic acetylcholine receptors | R-HSA-629597 | 7.962387e-01 | 0.099 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 7.962387e-01 | 0.099 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 7.962387e-01 | 0.099 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 7.962387e-01 | 0.099 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 7.962387e-01 | 0.099 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 7.979131e-01 | 0.098 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 7.979131e-01 | 0.098 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 7.994666e-01 | 0.097 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 8.007491e-01 | 0.097 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 8.039252e-01 | 0.095 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 8.039252e-01 | 0.095 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 8.063518e-01 | 0.093 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 8.063518e-01 | 0.093 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 8.063518e-01 | 0.093 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 8.063518e-01 | 0.093 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 8.063518e-01 | 0.093 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 8.075186e-01 | 0.093 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 8.075186e-01 | 0.093 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 8.078545e-01 | 0.093 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 8.078545e-01 | 0.093 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 8.078545e-01 | 0.093 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 8.078545e-01 | 0.093 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 8.078545e-01 | 0.093 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 8.150659e-01 | 0.089 | 1 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 8.157970e-01 | 0.088 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 8.164533e-01 | 0.088 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 8.181551e-01 | 0.087 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 8.201778e-01 | 0.086 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 8.218118e-01 | 0.085 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 8.236842e-01 | 0.084 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 8.236842e-01 | 0.084 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 8.236842e-01 | 0.084 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 8.236842e-01 | 0.084 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 8.236842e-01 | 0.084 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 8.236842e-01 | 0.084 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 8.236842e-01 | 0.084 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 8.236842e-01 | 0.084 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 8.236842e-01 | 0.084 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 8.236842e-01 | 0.084 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 8.236842e-01 | 0.084 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 8.236842e-01 | 0.084 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 8.241855e-01 | 0.084 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 8.246189e-01 | 0.084 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 8.246189e-01 | 0.084 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 8.264384e-01 | 0.083 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 8.264384e-01 | 0.083 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 8.264384e-01 | 0.083 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 8.264384e-01 | 0.083 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 8.264384e-01 | 0.083 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 8.264384e-01 | 0.083 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 8.264384e-01 | 0.083 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 8.264384e-01 | 0.083 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 8.264384e-01 | 0.083 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.286775e-01 | 0.082 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 8.291175e-01 | 0.081 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 8.302907e-01 | 0.081 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 8.339744e-01 | 0.079 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 8.349386e-01 | 0.078 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 8.349386e-01 | 0.078 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 8.387508e-01 | 0.076 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 8.389843e-01 | 0.076 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 8.404026e-01 | 0.076 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 8.425389e-01 | 0.074 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 8.425389e-01 | 0.074 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 8.425389e-01 | 0.074 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.425389e-01 | 0.074 | 0 | 0 |
| Activated point mutants of FGFR2 | R-HSA-2033519 | 8.446289e-01 | 0.073 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 8.446289e-01 | 0.073 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 8.446289e-01 | 0.073 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.447091e-01 | 0.073 | 1 | 1 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 8.472633e-01 | 0.072 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 8.472633e-01 | 0.072 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 8.474344e-01 | 0.072 | 0 | 0 |
| Highly calcium permeable postsynaptic nicotinic acetylcholine receptors | R-HSA-629594 | 8.474344e-01 | 0.072 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 8.474344e-01 | 0.072 | 0 | 0 |
| TET1,2,3 and TDG demethylate DNA | R-HSA-5221030 | 8.474344e-01 | 0.072 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 8.474344e-01 | 0.072 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 8.474344e-01 | 0.072 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 8.474344e-01 | 0.072 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 8.474344e-01 | 0.072 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 8.474344e-01 | 0.072 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 8.474344e-01 | 0.072 | 0 | 0 |
| Peptide hormone biosynthesis | R-HSA-209952 | 8.474344e-01 | 0.072 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 8.474344e-01 | 0.072 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 8.549415e-01 | 0.068 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 8.549415e-01 | 0.068 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 8.554438e-01 | 0.068 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 8.610694e-01 | 0.065 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 8.610694e-01 | 0.065 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 8.610694e-01 | 0.065 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 8.635216e-01 | 0.064 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 8.656475e-01 | 0.063 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 8.656475e-01 | 0.063 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 8.656475e-01 | 0.063 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 8.668845e-01 | 0.062 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 8.674372e-01 | 0.062 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 8.679865e-01 | 0.061 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 8.679865e-01 | 0.061 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 8.679865e-01 | 0.061 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 8.679865e-01 | 0.061 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 8.679865e-01 | 0.061 | 0 | 0 |
| Cholesterol biosynthesis via desmosterol | R-HSA-6807047 | 8.679865e-01 | 0.061 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 8.679865e-01 | 0.061 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 8.679865e-01 | 0.061 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 8.679865e-01 | 0.061 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 8.688354e-01 | 0.061 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 8.694565e-01 | 0.061 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 8.701306e-01 | 0.060 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 8.759014e-01 | 0.058 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 8.759014e-01 | 0.058 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 8.759014e-01 | 0.058 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 8.759014e-01 | 0.058 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 8.781284e-01 | 0.056 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 8.797309e-01 | 0.056 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 8.805756e-01 | 0.055 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 8.805756e-01 | 0.055 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 8.825735e-01 | 0.054 | 0 | 0 |
| Presynaptic nicotinic acetylcholine receptors | R-HSA-622323 | 8.857711e-01 | 0.053 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 8.857711e-01 | 0.053 | 0 | 0 |
| Endosomal/Vacuolar pathway | R-HSA-1236977 | 8.857711e-01 | 0.053 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 8.857711e-01 | 0.053 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 8.857711e-01 | 0.053 | 0 | 0 |
| FMO oxidises nucleophiles | R-HSA-217271 | 8.857711e-01 | 0.053 | 0 | 0 |
| Uptake of dietary cobalamins into enterocytes | R-HSA-9758881 | 8.857711e-01 | 0.053 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 8.874947e-01 | 0.052 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 8.891581e-01 | 0.051 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 8.891581e-01 | 0.051 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 8.892597e-01 | 0.051 | 0 | 0 |
| FGFR2 ligand binding and activation | R-HSA-190241 | 8.892597e-01 | 0.051 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 8.892597e-01 | 0.051 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 8.892597e-01 | 0.051 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 8.892597e-01 | 0.051 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 8.892597e-01 | 0.051 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 8.918148e-01 | 0.050 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 8.984068e-01 | 0.047 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 8.992596e-01 | 0.046 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 9.001884e-01 | 0.046 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 9.011606e-01 | 0.045 | 0 | 0 |
| Defective EXT2 causes exostoses 2 | R-HSA-3656237 | 9.011606e-01 | 0.045 | 0 | 0 |
| Defective EXT1 causes exostoses 1, TRPS2 and CHDS | R-HSA-3656253 | 9.011606e-01 | 0.045 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 9.011606e-01 | 0.045 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 9.011606e-01 | 0.045 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 9.011606e-01 | 0.045 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 9.011606e-01 | 0.045 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 9.011606e-01 | 0.045 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 9.011606e-01 | 0.045 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 9.011606e-01 | 0.045 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 9.011606e-01 | 0.045 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 9.012722e-01 | 0.045 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 9.012722e-01 | 0.045 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.015987e-01 | 0.045 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 9.072123e-01 | 0.042 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.097101e-01 | 0.041 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 9.110264e-01 | 0.040 | 0 | 0 |
| Free fatty acid receptors | R-HSA-444209 | 9.120589e-01 | 0.040 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 9.120589e-01 | 0.040 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.120589e-01 | 0.040 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 9.138993e-01 | 0.039 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.138993e-01 | 0.039 | 0 | 0 |
| Acetylcholine binding and downstream events | R-HSA-181431 | 9.144776e-01 | 0.039 | 0 | 0 |
| Postsynaptic nicotinic acetylcholine receptors | R-HSA-622327 | 9.144776e-01 | 0.039 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 9.144776e-01 | 0.039 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 9.144776e-01 | 0.039 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 9.144776e-01 | 0.039 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 9.144776e-01 | 0.039 | 0 | 0 |
| Mtb iron assimilation by chelation | R-HSA-1222449 | 9.144776e-01 | 0.039 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 9.144776e-01 | 0.039 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 9.144776e-01 | 0.039 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.149016e-01 | 0.039 | 1 | 0 |
| Kidney development | R-HSA-9830369 | 9.151840e-01 | 0.038 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 9.217321e-01 | 0.035 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.222647e-01 | 0.035 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.225928e-01 | 0.035 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.228134e-01 | 0.035 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 9.260010e-01 | 0.033 | 0 | 0 |
| Synthesis of IPs in the nucleus | R-HSA-1855191 | 9.260010e-01 | 0.033 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 9.260010e-01 | 0.033 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 9.260010e-01 | 0.033 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 9.260010e-01 | 0.033 | 0 | 0 |
| Biosynthesis of protectins | R-HSA-9018681 | 9.260010e-01 | 0.033 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 9.260010e-01 | 0.033 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 9.260010e-01 | 0.033 | 0 | 0 |
| Biosynthesis of E-series 18(R)-resolvins | R-HSA-9023661 | 9.260010e-01 | 0.033 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 9.260010e-01 | 0.033 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 9.260010e-01 | 0.033 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 9.260010e-01 | 0.033 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 9.260010e-01 | 0.033 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 9.260010e-01 | 0.033 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 9.272970e-01 | 0.033 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 9.278490e-01 | 0.033 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.296940e-01 | 0.032 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.296940e-01 | 0.032 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.302730e-01 | 0.031 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 9.303958e-01 | 0.031 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.303958e-01 | 0.031 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 9.323816e-01 | 0.030 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 9.325159e-01 | 0.030 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.349439e-01 | 0.029 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 9.359723e-01 | 0.029 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 9.359723e-01 | 0.029 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 9.359723e-01 | 0.029 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 9.359723e-01 | 0.029 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 9.359723e-01 | 0.029 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 9.359723e-01 | 0.029 | 0 | 0 |
| Dopamine clearance from the synaptic cleft | R-HSA-379401 | 9.359723e-01 | 0.029 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 9.359723e-01 | 0.029 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 9.359723e-01 | 0.029 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.377112e-01 | 0.028 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.378765e-01 | 0.028 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.381465e-01 | 0.028 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.381465e-01 | 0.028 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.381465e-01 | 0.028 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 9.389444e-01 | 0.027 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.405891e-01 | 0.027 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.433613e-01 | 0.025 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 9.446004e-01 | 0.025 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 9.446004e-01 | 0.025 | 0 | 0 |
| Activation of the phototransduction cascade | R-HSA-2485179 | 9.446004e-01 | 0.025 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 9.446004e-01 | 0.025 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.450729e-01 | 0.025 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 9.450729e-01 | 0.025 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.459461e-01 | 0.024 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 9.466561e-01 | 0.024 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.467116e-01 | 0.024 | 1 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.471333e-01 | 0.024 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 9.471333e-01 | 0.024 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.472389e-01 | 0.024 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.472389e-01 | 0.024 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.472612e-01 | 0.024 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 9.488857e-01 | 0.023 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 9.512562e-01 | 0.022 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.512562e-01 | 0.022 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.512562e-01 | 0.022 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 9.512562e-01 | 0.022 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.512562e-01 | 0.022 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.520016e-01 | 0.021 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 9.520663e-01 | 0.021 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 9.520663e-01 | 0.021 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 9.520663e-01 | 0.021 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 9.520663e-01 | 0.021 | 0 | 0 |
| Scavenging by Class B Receptors | R-HSA-3000471 | 9.520663e-01 | 0.021 | 0 | 0 |
| Vitamin B6 activation to pyridoxal phosphate | R-HSA-964975 | 9.520663e-01 | 0.021 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 9.520663e-01 | 0.021 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 9.525407e-01 | 0.021 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 9.564542e-01 | 0.019 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 9.567711e-01 | 0.019 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 9.567711e-01 | 0.019 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.567711e-01 | 0.019 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.573413e-01 | 0.019 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.573413e-01 | 0.019 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.580245e-01 | 0.019 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 9.585265e-01 | 0.018 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 9.585265e-01 | 0.018 | 0 | 0 |
| Biosynthesis of aspirin-triggered D-series resolvins | R-HSA-9020265 | 9.585265e-01 | 0.018 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 9.585265e-01 | 0.018 | 0 | 0 |
| Sulfide oxidation to sulfate | R-HSA-1614517 | 9.585265e-01 | 0.018 | 0 | 0 |
| GDP-fucose biosynthesis | R-HSA-6787639 | 9.585265e-01 | 0.018 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.607415e-01 | 0.017 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.616836e-01 | 0.017 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 9.616852e-01 | 0.017 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 9.616852e-01 | 0.017 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.616852e-01 | 0.017 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 9.641163e-01 | 0.016 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 9.641163e-01 | 0.016 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.641163e-01 | 0.016 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 9.641163e-01 | 0.016 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 9.641163e-01 | 0.016 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 9.656076e-01 | 0.015 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.656076e-01 | 0.015 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.660603e-01 | 0.015 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.660603e-01 | 0.015 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.672696e-01 | 0.014 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.676227e-01 | 0.014 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 9.685209e-01 | 0.014 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 9.689530e-01 | 0.014 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 9.689530e-01 | 0.014 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 9.689530e-01 | 0.014 | 0 | 0 |
| Methionine salvage pathway | R-HSA-1237112 | 9.689530e-01 | 0.014 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 9.689530e-01 | 0.014 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.691502e-01 | 0.014 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.699524e-01 | 0.013 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.699524e-01 | 0.013 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.705219e-01 | 0.013 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.707081e-01 | 0.013 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 9.731380e-01 | 0.012 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 9.731380e-01 | 0.012 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.731380e-01 | 0.012 | 0 | 0 |
| Keratan sulfate degradation | R-HSA-2022857 | 9.731380e-01 | 0.012 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 9.731380e-01 | 0.012 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.731380e-01 | 0.012 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 9.731686e-01 | 0.012 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 9.734123e-01 | 0.012 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 9.735167e-01 | 0.012 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.735167e-01 | 0.012 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 9.736331e-01 | 0.012 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.737405e-01 | 0.012 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 9.760712e-01 | 0.011 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 9.764856e-01 | 0.010 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.766884e-01 | 0.010 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 9.767591e-01 | 0.010 | 0 | 0 |
| Biosynthesis of E-series 18(S)-resolvins | R-HSA-9018896 | 9.767591e-01 | 0.010 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 9.767591e-01 | 0.010 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 9.768749e-01 | 0.010 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 9.778187e-01 | 0.010 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.778187e-01 | 0.010 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.780854e-01 | 0.010 | 1 | 0 |
| Neddylation | R-HSA-8951664 | 9.786728e-01 | 0.009 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.792137e-01 | 0.009 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.792137e-01 | 0.009 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.795911e-01 | 0.009 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.798922e-01 | 0.009 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.798922e-01 | 0.009 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 9.798922e-01 | 0.009 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 9.798922e-01 | 0.009 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.801520e-01 | 0.009 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.801520e-01 | 0.009 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.816338e-01 | 0.008 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.816957e-01 | 0.008 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.818894e-01 | 0.008 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.819953e-01 | 0.008 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.824130e-01 | 0.008 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.825565e-01 | 0.008 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.826031e-01 | 0.008 | 0 | 0 |
| Biosynthesis of D-series resolvins | R-HSA-9018676 | 9.826031e-01 | 0.008 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.826031e-01 | 0.008 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.832457e-01 | 0.007 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 9.837794e-01 | 0.007 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.837794e-01 | 0.007 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 9.841346e-01 | 0.007 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.841470e-01 | 0.007 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.847242e-01 | 0.007 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 9.849487e-01 | 0.007 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 9.849487e-01 | 0.007 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.849487e-01 | 0.007 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.849487e-01 | 0.007 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.849487e-01 | 0.007 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 9.849487e-01 | 0.007 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.856804e-01 | 0.006 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 9.856804e-01 | 0.006 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.856804e-01 | 0.006 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 9.858267e-01 | 0.006 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 9.860912e-01 | 0.006 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.869781e-01 | 0.006 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.869781e-01 | 0.006 | 0 | 0 |
| Synthesis of dolichyl-phosphate | R-HSA-446199 | 9.869781e-01 | 0.006 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.869781e-01 | 0.006 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.871401e-01 | 0.006 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 9.873638e-01 | 0.006 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.873638e-01 | 0.006 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.873638e-01 | 0.006 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.873638e-01 | 0.006 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.884268e-01 | 0.005 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.886499e-01 | 0.005 | 0 | 0 |
| Alpha-oxidation of phytanate | R-HSA-389599 | 9.887340e-01 | 0.005 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.887340e-01 | 0.005 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.887340e-01 | 0.005 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.887340e-01 | 0.005 | 0 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 9.887340e-01 | 0.005 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.888537e-01 | 0.005 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.888537e-01 | 0.005 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.895901e-01 | 0.005 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.898879e-01 | 0.004 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.901717e-01 | 0.004 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.902533e-01 | 0.004 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.902533e-01 | 0.004 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 9.902533e-01 | 0.004 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.904510e-01 | 0.004 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.904606e-01 | 0.004 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.906412e-01 | 0.004 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.910176e-01 | 0.004 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.910176e-01 | 0.004 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 9.913370e-01 | 0.004 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.915677e-01 | 0.004 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.915677e-01 | 0.004 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 9.919949e-01 | 0.003 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.923668e-01 | 0.003 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.923668e-01 | 0.003 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.927049e-01 | 0.003 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.932765e-01 | 0.003 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.932765e-01 | 0.003 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.933790e-01 | 0.003 | 1 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.936505e-01 | 0.003 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.936888e-01 | 0.003 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 9.936888e-01 | 0.003 | 0 | 0 |
| Biosynthesis of EPA-derived SPMs | R-HSA-9018679 | 9.936888e-01 | 0.003 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.944835e-01 | 0.002 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.944835e-01 | 0.002 | 0 | 0 |
| Mucopolysaccharidoses | R-HSA-2206281 | 9.945401e-01 | 0.002 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.947887e-01 | 0.002 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.947887e-01 | 0.002 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.948949e-01 | 0.002 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.951070e-01 | 0.002 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.951425e-01 | 0.002 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.951535e-01 | 0.002 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 9.952766e-01 | 0.002 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 9.952766e-01 | 0.002 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 9.952766e-01 | 0.002 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.954141e-01 | 0.002 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 9.959657e-01 | 0.002 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 9.959657e-01 | 0.002 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.959657e-01 | 0.002 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.959657e-01 | 0.002 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.959657e-01 | 0.002 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.960720e-01 | 0.002 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.960871e-01 | 0.002 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.964675e-01 | 0.002 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.967424e-01 | 0.001 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.968619e-01 | 0.001 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.968619e-01 | 0.001 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.968805e-01 | 0.001 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 9.969419e-01 | 0.001 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.970292e-01 | 0.001 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.970292e-01 | 0.001 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.972133e-01 | 0.001 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.972580e-01 | 0.001 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.972580e-01 | 0.001 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.973358e-01 | 0.001 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.973545e-01 | 0.001 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.973545e-01 | 0.001 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.973545e-01 | 0.001 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.974808e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts via 24-hydroxycholesterol | R-HSA-193775 | 9.977115e-01 | 0.001 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.977704e-01 | 0.001 | 0 | 0 |
| HS-GAG biosynthesis | R-HSA-2022928 | 9.980203e-01 | 0.001 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 9.980203e-01 | 0.001 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.980203e-01 | 0.001 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 9.981407e-01 | 0.001 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.982874e-01 | 0.001 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.982874e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.982874e-01 | 0.001 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.983940e-01 | 0.001 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.984036e-01 | 0.001 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.985185e-01 | 0.001 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.985667e-01 | 0.001 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.986008e-01 | 0.001 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.986431e-01 | 0.001 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.987178e-01 | 0.001 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.987185e-01 | 0.001 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.987518e-01 | 0.001 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.987518e-01 | 0.001 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.988180e-01 | 0.001 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.988914e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.989368e-01 | 0.000 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.990315e-01 | 0.000 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.990411e-01 | 0.000 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 9.990411e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.990474e-01 | 0.000 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.990570e-01 | 0.000 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.991505e-01 | 0.000 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.991652e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.991652e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.991652e-01 | 0.000 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.991652e-01 | 0.000 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.991705e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.992247e-01 | 0.000 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.992612e-01 | 0.000 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.993017e-01 | 0.000 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 9.993468e-01 | 0.000 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.993468e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.993586e-01 | 0.000 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 9.993793e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.994229e-01 | 0.000 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.994280e-01 | 0.000 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.994631e-01 | 0.000 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.994887e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.995113e-01 | 0.000 | 1 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.995356e-01 | 0.000 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.995356e-01 | 0.000 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.995983e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.996329e-01 | 0.000 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 9.996470e-01 | 0.000 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.996526e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.996625e-01 | 0.000 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.996625e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.996792e-01 | 0.000 | 0 | 0 |
| Keratan sulfate/keratin metabolism | R-HSA-1638074 | 9.997401e-01 | 0.000 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.997401e-01 | 0.000 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.997479e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.997568e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.997733e-01 | 0.000 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.997733e-01 | 0.000 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.997752e-01 | 0.000 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.998055e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.998083e-01 | 0.000 | 1 | 1 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.998327e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.998480e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.998607e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.998670e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.998852e-01 | 0.000 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.998912e-01 | 0.000 | 0 | 0 |
| Digestion | R-HSA-8935690 | 9.999059e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.999221e-01 | 0.000 | 0 | 0 |
| Sialic acid metabolism | R-HSA-4085001 | 9.999391e-01 | 0.000 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.999391e-01 | 0.000 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.999473e-01 | 0.000 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.999545e-01 | 0.000 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.999633e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.999653e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.999659e-01 | 0.000 | 0 | 0 |
| Digestion and absorption | R-HSA-8963743 | 9.999659e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.999732e-01 | 0.000 | 0 | 0 |
| Latent infection - Other responses of Mtb to phagocytosis | R-HSA-1222499 | 9.999745e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.999809e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999812e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999830e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.999835e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999863e-01 | 0.000 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.999865e-01 | 0.000 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.999882e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.999908e-01 | 0.000 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.999920e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.999920e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999943e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.999948e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.999954e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999954e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.999961e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999964e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.999967e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999970e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999970e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999976e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999977e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999988e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999991e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999996e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999996e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999996e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.999998e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999999e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999999e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999999e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999999e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999999e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 1.000000e+00 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 1.000000e+00 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | -0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle, Mitotic | R-HSA-69278 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.110223e-16 | 15.955 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.110223e-16 | 15.955 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.665335e-15 | 14.778 | 1 | 0 |
| Mitotic Prophase | R-HSA-68875 | 2.192690e-13 | 12.659 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.139977e-12 | 11.943 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 1.020595e-11 | 10.991 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 9.811818e-12 | 11.008 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.091216e-11 | 10.962 | 1 | 0 |
| Nervous system development | R-HSA-9675108 | 1.281908e-11 | 10.892 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.541189e-11 | 10.812 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.494393e-11 | 10.826 | 1 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 2.981793e-11 | 10.526 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 4.697742e-11 | 10.328 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 6.004452e-11 | 10.222 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 8.527046e-11 | 10.069 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 1.069734e-10 | 9.971 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.375176e-10 | 9.862 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 1.406806e-10 | 9.852 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.548457e-10 | 9.810 | 1 | 0 |
| Axon guidance | R-HSA-422475 | 1.609483e-10 | 9.793 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 3.976558e-10 | 9.400 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 4.235975e-10 | 9.373 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 5.276336e-10 | 9.278 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 6.035829e-10 | 9.219 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.021168e-09 | 8.991 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.190914e-09 | 8.924 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.254134e-09 | 8.902 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 1.723560e-09 | 8.764 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.988388e-09 | 8.701 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 2.443899e-09 | 8.612 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 2.462719e-09 | 8.609 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 2.650567e-09 | 8.577 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 2.605085e-09 | 8.584 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 2.763801e-09 | 8.558 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 3.412447e-09 | 8.467 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 4.048174e-09 | 8.393 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 4.012790e-09 | 8.397 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 3.993950e-09 | 8.399 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 4.384527e-09 | 8.358 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 5.120050e-09 | 8.291 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 6.118960e-09 | 8.213 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 6.118960e-09 | 8.213 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 9.503330e-09 | 8.022 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 9.630065e-09 | 8.016 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.094399e-08 | 7.961 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 1.311559e-08 | 7.882 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.399016e-08 | 7.854 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.484382e-08 | 7.828 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.524531e-08 | 7.817 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.587815e-08 | 7.799 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 1.896517e-08 | 7.722 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 2.514618e-08 | 7.600 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 2.921770e-08 | 7.534 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 3.236484e-08 | 7.490 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 3.516095e-08 | 7.454 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 4.583796e-08 | 7.339 | 1 | 1 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 4.583796e-08 | 7.339 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 5.365612e-08 | 7.270 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 5.470333e-08 | 7.262 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 8.437871e-08 | 7.074 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 8.711254e-08 | 7.060 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.338307e-08 | 7.030 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.379970e-07 | 6.860 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 1.392366e-07 | 6.856 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.404093e-07 | 6.853 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 1.573251e-07 | 6.803 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 1.634840e-07 | 6.787 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 1.634840e-07 | 6.787 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.858876e-07 | 6.731 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.858876e-07 | 6.731 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 2.107829e-07 | 6.676 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 2.567215e-07 | 6.591 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 2.662684e-07 | 6.575 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 3.045955e-07 | 6.516 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 3.012435e-07 | 6.521 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 3.075956e-07 | 6.512 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 3.182551e-07 | 6.497 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 3.247722e-07 | 6.488 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 3.247722e-07 | 6.488 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 3.425749e-07 | 6.465 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 3.610920e-07 | 6.442 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 4.143710e-07 | 6.383 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 4.143710e-07 | 6.383 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 4.137571e-07 | 6.383 | 0 | 0 |
| Kinesins | R-HSA-983189 | 4.957411e-07 | 6.305 | 0 | 0 |
| Depurination | R-HSA-73927 | 5.752585e-07 | 6.240 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 5.901618e-07 | 6.229 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 6.733120e-07 | 6.172 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 6.914672e-07 | 6.160 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 7.790288e-07 | 6.108 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 9.791369e-07 | 6.009 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.123937e-06 | 5.949 | 1 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.207701e-06 | 5.918 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.220603e-06 | 5.913 | 1 | 0 |
| Meiosis | R-HSA-1500620 | 1.288280e-06 | 5.890 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.454136e-06 | 5.837 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.699168e-06 | 5.770 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 2.029854e-06 | 5.693 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 2.375125e-06 | 5.624 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 2.794492e-06 | 5.554 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 2.803660e-06 | 5.552 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 2.814849e-06 | 5.551 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 3.048523e-06 | 5.516 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 3.599953e-06 | 5.444 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 3.630878e-06 | 5.440 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 3.842859e-06 | 5.415 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 4.271211e-06 | 5.369 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 4.509028e-06 | 5.346 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 4.633688e-06 | 5.334 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 5.123194e-06 | 5.290 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 5.001656e-06 | 5.301 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 5.112088e-06 | 5.291 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 5.544613e-06 | 5.256 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 5.612858e-06 | 5.251 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 5.612858e-06 | 5.251 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 6.187798e-06 | 5.208 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 6.195751e-06 | 5.208 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 7.219483e-06 | 5.141 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 9.964280e-06 | 5.002 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.031832e-05 | 4.986 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 1.135905e-05 | 4.945 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.222695e-05 | 4.913 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 1.295772e-05 | 4.887 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 1.295772e-05 | 4.887 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 1.365344e-05 | 4.865 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.365344e-05 | 4.865 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.365344e-05 | 4.865 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.600144e-05 | 4.796 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.600144e-05 | 4.796 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 1.601684e-05 | 4.795 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.706326e-05 | 4.768 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 1.936170e-05 | 4.713 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 2.197997e-05 | 4.658 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 2.469292e-05 | 4.607 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 2.482372e-05 | 4.605 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 2.484570e-05 | 4.605 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 2.634137e-05 | 4.579 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 3.011721e-05 | 4.521 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 2.887200e-05 | 4.540 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 2.804937e-05 | 4.552 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 3.105049e-05 | 4.508 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 3.297401e-05 | 4.482 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 3.427952e-05 | 4.465 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 3.594350e-05 | 4.444 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 3.768933e-05 | 4.424 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 4.041942e-05 | 4.393 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 4.148230e-05 | 4.382 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 4.206281e-05 | 4.376 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 4.438604e-05 | 4.353 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 4.785581e-05 | 4.320 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 4.785581e-05 | 4.320 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 4.509499e-05 | 4.346 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 4.426085e-05 | 4.354 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 4.809427e-05 | 4.318 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 5.339773e-05 | 4.272 | 1 | 0 |
| Reproduction | R-HSA-1474165 | 5.379193e-05 | 4.269 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 5.660149e-05 | 4.247 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 5.672063e-05 | 4.246 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 5.756816e-05 | 4.240 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 7.330601e-05 | 4.135 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 7.885480e-05 | 4.103 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 8.030168e-05 | 4.095 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 8.030168e-05 | 4.095 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 8.805327e-05 | 4.055 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 8.805327e-05 | 4.055 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 9.157853e-05 | 4.038 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 9.652292e-05 | 4.015 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 9.652292e-05 | 4.015 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.025942e-04 | 3.989 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 9.356480e-05 | 4.029 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 1.032160e-04 | 3.986 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.092611e-04 | 3.962 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.174813e-04 | 3.930 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.240591e-04 | 3.906 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.255731e-04 | 3.901 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.295852e-04 | 3.887 | 1 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.454134e-04 | 3.837 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 1.548655e-04 | 3.810 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.651578e-04 | 3.782 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.967505e-04 | 3.706 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.066780e-04 | 3.685 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 2.073021e-04 | 3.683 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 2.346530e-04 | 3.630 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 2.364423e-04 | 3.626 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 2.508453e-04 | 3.601 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 2.519146e-04 | 3.599 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 2.705414e-04 | 3.568 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 2.750770e-04 | 3.561 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 2.998112e-04 | 3.523 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 3.278321e-04 | 3.484 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 3.563368e-04 | 3.448 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 3.563368e-04 | 3.448 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 3.637651e-04 | 3.439 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 4.232355e-04 | 3.373 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 4.269608e-04 | 3.370 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 4.693244e-04 | 3.329 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 4.839860e-04 | 3.315 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 5.117940e-04 | 3.291 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 5.491370e-04 | 3.260 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 5.528633e-04 | 3.257 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 6.031428e-04 | 3.220 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 6.378436e-04 | 3.195 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 6.493046e-04 | 3.188 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 6.873121e-04 | 3.163 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 7.073248e-04 | 3.150 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 7.073248e-04 | 3.150 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 7.815139e-04 | 3.107 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 9.225279e-04 | 3.035 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 8.272985e-04 | 3.082 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 8.813772e-04 | 3.055 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 8.845086e-04 | 3.053 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 9.708726e-04 | 3.013 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 9.708726e-04 | 3.013 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.022227e-03 | 2.990 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 1.040554e-03 | 2.983 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.115250e-03 | 2.953 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.135978e-03 | 2.945 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 1.145735e-03 | 2.941 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.280469e-03 | 2.893 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 1.322351e-03 | 2.879 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 1.334160e-03 | 2.875 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.429894e-03 | 2.845 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.458158e-03 | 2.836 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.560705e-03 | 2.807 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 1.663295e-03 | 2.779 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.728329e-03 | 2.762 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.779590e-03 | 2.750 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.796938e-03 | 2.745 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 1.822936e-03 | 2.739 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 1.877765e-03 | 2.726 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.891504e-03 | 2.723 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 2.106402e-03 | 2.676 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 2.155920e-03 | 2.666 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 2.393370e-03 | 2.621 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 2.393370e-03 | 2.621 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 2.393370e-03 | 2.621 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 2.444789e-03 | 2.612 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 2.504946e-03 | 2.601 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 2.548843e-03 | 2.594 | 1 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 2.860146e-03 | 2.544 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 2.560949e-03 | 2.592 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 2.667072e-03 | 2.574 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 2.985540e-03 | 2.525 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 2.622530e-03 | 2.581 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 3.127722e-03 | 2.505 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 3.169940e-03 | 2.499 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 3.182492e-03 | 2.497 | 1 | 0 |
| Protein folding | R-HSA-391251 | 3.335316e-03 | 2.477 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 3.508295e-03 | 2.455 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 3.704001e-03 | 2.431 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 3.852538e-03 | 2.414 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 3.853855e-03 | 2.414 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 3.876895e-03 | 2.412 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 3.878382e-03 | 2.411 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 3.986647e-03 | 2.399 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 4.093902e-03 | 2.388 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 4.114349e-03 | 2.386 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 4.596307e-03 | 2.338 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 5.095426e-03 | 2.293 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 5.104424e-03 | 2.292 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 5.134171e-03 | 2.290 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 5.313208e-03 | 2.275 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 5.527134e-03 | 2.257 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 5.556059e-03 | 2.255 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 5.556059e-03 | 2.255 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 5.559588e-03 | 2.255 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 5.669425e-03 | 2.246 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 5.734897e-03 | 2.241 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 6.414898e-03 | 2.193 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 6.447703e-03 | 2.191 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 6.583609e-03 | 2.182 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 6.583609e-03 | 2.182 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 6.583609e-03 | 2.182 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 6.603364e-03 | 2.180 | 1 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 6.765211e-03 | 2.170 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 6.870469e-03 | 2.163 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 7.438088e-03 | 2.129 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 7.438088e-03 | 2.129 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 7.602796e-03 | 2.119 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 9.004525e-03 | 2.046 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 8.729703e-03 | 2.059 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 7.867006e-03 | 2.104 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 9.006970e-03 | 2.045 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 7.867006e-03 | 2.104 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 8.506233e-03 | 2.070 | 1 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 8.603987e-03 | 2.065 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 8.492492e-03 | 2.071 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 9.162230e-03 | 2.038 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 9.227826e-03 | 2.035 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 9.312799e-03 | 2.031 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 9.348382e-03 | 2.029 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 9.348382e-03 | 2.029 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 9.520758e-03 | 2.021 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 9.842354e-03 | 2.007 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 9.901460e-03 | 2.004 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.008288e-02 | 1.996 | 1 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 1.008793e-02 | 1.996 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.052663e-02 | 1.978 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 1.063783e-02 | 1.973 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 1.063783e-02 | 1.973 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 1.095177e-02 | 1.961 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 1.095177e-02 | 1.961 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.109403e-02 | 1.955 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.183281e-02 | 1.927 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 1.220775e-02 | 1.913 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.282303e-02 | 1.892 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.337490e-02 | 1.874 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 1.337490e-02 | 1.874 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.337490e-02 | 1.874 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.337490e-02 | 1.874 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.337490e-02 | 1.874 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 1.363829e-02 | 1.865 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 1.376883e-02 | 1.861 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 1.406497e-02 | 1.852 | 1 | 1 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.419466e-02 | 1.848 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.446017e-02 | 1.840 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 1.506461e-02 | 1.822 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 1.520926e-02 | 1.818 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.529943e-02 | 1.815 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.529943e-02 | 1.815 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 1.530100e-02 | 1.815 | 1 | 1 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.530100e-02 | 1.815 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.538615e-02 | 1.813 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 1.571287e-02 | 1.804 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 1.571287e-02 | 1.804 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.625220e-02 | 1.789 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 1.628979e-02 | 1.788 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 1.628979e-02 | 1.788 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 1.670062e-02 | 1.777 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.707944e-02 | 1.768 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 1.714552e-02 | 1.766 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 1.716194e-02 | 1.765 | 1 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 1.792757e-02 | 1.746 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.819892e-02 | 1.740 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.852510e-02 | 1.732 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 1.914636e-02 | 1.718 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.995680e-02 | 1.700 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 1.995680e-02 | 1.700 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 2.209147e-02 | 1.656 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 2.209147e-02 | 1.656 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 2.218028e-02 | 1.654 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.478121e-02 | 1.606 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 2.211867e-02 | 1.655 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 2.020518e-02 | 1.695 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 2.188520e-02 | 1.660 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 2.176062e-02 | 1.662 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 2.494816e-02 | 1.603 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 2.494816e-02 | 1.603 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 2.376584e-02 | 1.624 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 2.278872e-02 | 1.642 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 2.021961e-02 | 1.694 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 2.514063e-02 | 1.600 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 2.562303e-02 | 1.591 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 2.572377e-02 | 1.590 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 2.608414e-02 | 1.584 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 2.608414e-02 | 1.584 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 2.647233e-02 | 1.577 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 2.650400e-02 | 1.577 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 2.729258e-02 | 1.564 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 2.729258e-02 | 1.564 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 2.760068e-02 | 1.559 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 2.817787e-02 | 1.550 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 2.817787e-02 | 1.550 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 2.817787e-02 | 1.550 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 2.817787e-02 | 1.550 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 2.817787e-02 | 1.550 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 2.817787e-02 | 1.550 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 2.984583e-02 | 1.525 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 3.142248e-02 | 1.503 | 0 | 0 |
| S Phase | R-HSA-69242 | 3.149034e-02 | 1.502 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 3.152790e-02 | 1.501 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 3.287953e-02 | 1.483 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 3.295319e-02 | 1.482 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 3.425541e-02 | 1.465 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 3.459384e-02 | 1.461 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 3.631165e-02 | 1.440 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 3.693549e-02 | 1.433 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 3.729725e-02 | 1.428 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 3.734919e-02 | 1.428 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 3.734919e-02 | 1.428 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 3.839989e-02 | 1.416 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 3.871854e-02 | 1.412 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 3.901916e-02 | 1.409 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 3.901916e-02 | 1.409 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 3.901916e-02 | 1.409 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 3.901916e-02 | 1.409 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 4.023526e-02 | 1.395 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 4.023526e-02 | 1.395 | 0 | 0 |
| Transport of glycerol from adipocytes to the liver by Aquaporins | R-HSA-432030 | 4.023526e-02 | 1.395 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 4.023526e-02 | 1.395 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 4.023526e-02 | 1.395 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 4.105970e-02 | 1.387 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 4.132521e-02 | 1.384 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 4.145235e-02 | 1.382 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 4.301632e-02 | 1.366 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 4.301632e-02 | 1.366 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 4.415836e-02 | 1.355 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 4.415836e-02 | 1.355 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 4.455081e-02 | 1.351 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 4.765267e-02 | 1.322 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 4.765267e-02 | 1.322 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 4.827790e-02 | 1.316 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 4.962728e-02 | 1.304 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 4.962728e-02 | 1.304 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 5.007809e-02 | 1.300 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 5.114487e-02 | 1.291 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 5.173340e-02 | 1.286 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 5.190485e-02 | 1.285 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 5.190485e-02 | 1.285 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 5.190485e-02 | 1.285 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 5.285074e-02 | 1.277 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 5.460080e-02 | 1.263 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 5.546920e-02 | 1.256 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 5.648805e-02 | 1.248 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 5.648805e-02 | 1.248 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 5.648805e-02 | 1.248 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 6.684925e-02 | 1.175 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 6.166092e-02 | 1.210 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 6.166092e-02 | 1.210 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 6.166092e-02 | 1.210 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 6.166092e-02 | 1.210 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 7.508840e-02 | 1.124 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 7.751176e-02 | 1.111 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 7.751176e-02 | 1.111 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 6.214895e-02 | 1.207 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 6.339609e-02 | 1.198 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 6.859059e-02 | 1.164 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 6.723112e-02 | 1.172 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 7.751176e-02 | 1.111 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 7.906281e-02 | 1.102 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 7.265426e-02 | 1.139 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 6.776972e-02 | 1.169 | 0 | 0 |
| tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis | R-HSA-9708296 | 6.684925e-02 | 1.175 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 6.631016e-02 | 1.178 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 7.872524e-02 | 1.104 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 6.332084e-02 | 1.198 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 6.159074e-02 | 1.210 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 7.508840e-02 | 1.124 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 6.438587e-02 | 1.191 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 7.878378e-02 | 1.104 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 6.854007e-02 | 1.164 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 6.166092e-02 | 1.210 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 6.072482e-02 | 1.217 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 8.231439e-02 | 1.085 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 8.339827e-02 | 1.079 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 8.566435e-02 | 1.067 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 8.566435e-02 | 1.067 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 8.714934e-02 | 1.060 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 8.714934e-02 | 1.060 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 8.800072e-02 | 1.056 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 8.842783e-02 | 1.053 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 8.842783e-02 | 1.053 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 8.945017e-02 | 1.048 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 8.945017e-02 | 1.048 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 8.985857e-02 | 1.046 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 8.985857e-02 | 1.046 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 8.985857e-02 | 1.046 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 8.985857e-02 | 1.046 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 8.985857e-02 | 1.046 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 8.985857e-02 | 1.046 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 8.985857e-02 | 1.046 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 8.985857e-02 | 1.046 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 8.985857e-02 | 1.046 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 9.728753e-02 | 1.012 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 9.768016e-02 | 1.010 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 9.768016e-02 | 1.010 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 9.922450e-02 | 1.003 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 9.957693e-02 | 1.002 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 9.957693e-02 | 1.002 | 0 | 0 |
| Deletions in the AMER1 gene destabilize the destruction complex | R-HSA-5467343 | 9.957693e-02 | 1.002 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 9.957693e-02 | 1.002 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 1.033103e-01 | 0.986 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 1.059037e-01 | 0.975 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 1.059037e-01 | 0.975 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.077249e-01 | 0.968 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 1.079862e-01 | 0.967 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 1.097842e-01 | 0.959 | 1 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 1.103096e-01 | 0.957 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.103096e-01 | 0.957 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.103692e-01 | 0.957 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.103996e-01 | 0.957 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 1.105825e-01 | 0.956 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.154244e-01 | 0.938 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 1.183945e-01 | 0.927 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 1.200746e-01 | 0.921 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 1.231426e-01 | 0.910 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 1.231426e-01 | 0.910 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 1.240998e-01 | 0.906 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 1.255790e-01 | 0.901 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 1.255790e-01 | 0.901 | 0 | 0 |
| Activation, translocation and oligomerization of BAX | R-HSA-114294 | 1.892436e-01 | 0.723 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.892436e-01 | 0.723 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.892436e-01 | 0.723 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.892436e-01 | 0.723 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.892436e-01 | 0.723 | 0 | 0 |
| Defective Mismatch Repair Associated With MLH1 | R-HSA-5545483 | 1.892436e-01 | 0.723 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 1.892436e-01 | 0.723 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.892436e-01 | 0.723 | 0 | 0 |
| Defective Mismatch Repair Associated With PMS2 | R-HSA-5632987 | 1.892436e-01 | 0.723 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.892436e-01 | 0.723 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 1.316253e-01 | 0.881 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 1.316253e-01 | 0.881 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 1.316253e-01 | 0.881 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 1.316253e-01 | 0.881 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 1.316253e-01 | 0.881 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 1.316253e-01 | 0.881 | 0 | 0 |
| PTK6 Activates STAT3 | R-HSA-8849474 | 1.677596e-01 | 0.775 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 1.677596e-01 | 0.775 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 1.677596e-01 | 0.775 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 1.677596e-01 | 0.775 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.677596e-01 | 0.775 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 1.677596e-01 | 0.775 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 1.677596e-01 | 0.775 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 1.677596e-01 | 0.775 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.677596e-01 | 0.775 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 1.677596e-01 | 0.775 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.334107e-01 | 0.875 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 1.576992e-01 | 0.802 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 1.576992e-01 | 0.802 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.832117e-01 | 0.737 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 1.414832e-01 | 0.849 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 1.414832e-01 | 0.849 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.608254e-01 | 0.794 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 1.810631e-01 | 0.742 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 1.810631e-01 | 0.742 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 1.371065e-01 | 0.863 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 1.740864e-01 | 0.759 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 1.510483e-01 | 0.821 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 1.510483e-01 | 0.821 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 1.655930e-01 | 0.781 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 1.655930e-01 | 0.781 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.439969e-01 | 0.842 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 1.841100e-01 | 0.735 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 1.751500e-01 | 0.757 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 1.595207e-01 | 0.797 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 1.758595e-01 | 0.755 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.576992e-01 | 0.802 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 1.414832e-01 | 0.849 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 1.699962e-01 | 0.770 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.334107e-01 | 0.875 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.414832e-01 | 0.849 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 1.843592e-01 | 0.734 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 1.316253e-01 | 0.881 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.597966e-01 | 0.796 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 1.439969e-01 | 0.842 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.334107e-01 | 0.875 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.319350e-01 | 0.880 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 1.366985e-01 | 0.864 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 1.597966e-01 | 0.796 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 1.655930e-01 | 0.781 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 1.719887e-01 | 0.765 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 1.827571e-01 | 0.738 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 1.827571e-01 | 0.738 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 1.827571e-01 | 0.738 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 1.827571e-01 | 0.738 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.719887e-01 | 0.765 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 1.808154e-01 | 0.743 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 1.892436e-01 | 0.723 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 1.892436e-01 | 0.723 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.316253e-01 | 0.881 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 1.316253e-01 | 0.881 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 1.608254e-01 | 0.794 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 1.571799e-01 | 0.804 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.407460e-01 | 0.852 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 1.334107e-01 | 0.875 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 1.409915e-01 | 0.851 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.726597e-01 | 0.763 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 1.839439e-01 | 0.735 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 1.655930e-01 | 0.781 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.701412e-01 | 0.769 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 1.827571e-01 | 0.738 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 1.576992e-01 | 0.802 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 1.832117e-01 | 0.737 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 1.409915e-01 | 0.851 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.832117e-01 | 0.737 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.810631e-01 | 0.742 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 1.688653e-01 | 0.772 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 1.409915e-01 | 0.851 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.414832e-01 | 0.849 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 1.399789e-01 | 0.854 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 1.322980e-01 | 0.878 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 1.818974e-01 | 0.740 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 1.916498e-01 | 0.717 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 1.947201e-01 | 0.711 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 1.961149e-01 | 0.707 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 1.978704e-01 | 0.704 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.998824e-01 | 0.699 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.020871e-01 | 0.694 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.020871e-01 | 0.694 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.020871e-01 | 0.694 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 2.020871e-01 | 0.694 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 2.020871e-01 | 0.694 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 2.020871e-01 | 0.694 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 2.053112e-01 | 0.688 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 2.053112e-01 | 0.688 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 2.053112e-01 | 0.688 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 2.053112e-01 | 0.688 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 2.053112e-01 | 0.688 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 2.053112e-01 | 0.688 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 2.053112e-01 | 0.688 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 2.097164e-01 | 0.678 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 2.097164e-01 | 0.678 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 2.097164e-01 | 0.678 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 2.097164e-01 | 0.678 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 2.097164e-01 | 0.678 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 2.098057e-01 | 0.678 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 2.108984e-01 | 0.676 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 2.108984e-01 | 0.676 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 2.124545e-01 | 0.673 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 2.124545e-01 | 0.673 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 2.146400e-01 | 0.668 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 2.184525e-01 | 0.661 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 2.212607e-01 | 0.655 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 2.212607e-01 | 0.655 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.237863e-01 | 0.650 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 2.237863e-01 | 0.650 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 2.237863e-01 | 0.650 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 2.237863e-01 | 0.650 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 2.237863e-01 | 0.650 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 2.273857e-01 | 0.643 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 2.284879e-01 | 0.641 | 0 | 0 |
| Mitochondrial short-chain enoyl-CoA hydratase deficiency 1 | R-HSA-9916720 | 2.699857e-01 | 0.569 | 0 | 0 |
| Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 | R-HSA-5083628 | 2.699857e-01 | 0.569 | 0 | 0 |
| TALDO1 deficiency: failed conversion of Fru(6)P, E4P to SH7P, GA3P | R-HSA-6791462 | 2.699857e-01 | 0.569 | 0 | 0 |
| Defective MMADHC causes MMAHCD | R-HSA-3359473 | 2.699857e-01 | 0.569 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.699857e-01 | 0.569 | 0 | 0 |
| TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P | R-HSA-6791055 | 2.699857e-01 | 0.569 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 2.699857e-01 | 0.569 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 3.426911e-01 | 0.465 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 3.426911e-01 | 0.465 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 3.426911e-01 | 0.465 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 3.426911e-01 | 0.465 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 3.426911e-01 | 0.465 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 3.426911e-01 | 0.465 | 0 | 0 |
| Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 | R-HSA-5083633 | 3.426911e-01 | 0.465 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 3.426911e-01 | 0.465 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 3.426911e-01 | 0.465 | 0 | 0 |
| Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 | R-HSA-5083629 | 3.426911e-01 | 0.465 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 3.426911e-01 | 0.465 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 3.426911e-01 | 0.465 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 3.426911e-01 | 0.465 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 3.426911e-01 | 0.465 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.426911e-01 | 0.465 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 3.426911e-01 | 0.465 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 3.426911e-01 | 0.465 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 2.436399e-01 | 0.613 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 2.436399e-01 | 0.613 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 2.822190e-01 | 0.549 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.822190e-01 | 0.549 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 2.822190e-01 | 0.549 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 2.822190e-01 | 0.549 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 2.822190e-01 | 0.549 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 4.081594e-01 | 0.389 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 4.081594e-01 | 0.389 | 0 | 0 |
| Defective MMACHC causes MAHCC | R-HSA-3359474 | 4.081594e-01 | 0.389 | 0 | 0 |
| Adrenaline signalling through Alpha-2 adrenergic receptor | R-HSA-392023 | 4.081594e-01 | 0.389 | 0 | 0 |
| Defective SLC7A7 causes lysinuric protein intolerance (LPI) | R-HSA-5660862 | 4.081594e-01 | 0.389 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 4.081594e-01 | 0.389 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 4.081594e-01 | 0.389 | 0 | 0 |
| Signalling to STAT3 | R-HSA-198745 | 4.081594e-01 | 0.389 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 4.081594e-01 | 0.389 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 2.369905e-01 | 0.625 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 2.369905e-01 | 0.625 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 2.369905e-01 | 0.625 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 3.206189e-01 | 0.494 | 0 | 0 |
| RSK activation | R-HSA-444257 | 3.206189e-01 | 0.494 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 3.206189e-01 | 0.494 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 3.206189e-01 | 0.494 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 3.206189e-01 | 0.494 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 3.206189e-01 | 0.494 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 2.648228e-01 | 0.577 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 2.648228e-01 | 0.577 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 2.460499e-01 | 0.609 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 3.584929e-01 | 0.446 | 1 | 1 |
| Interleukin-21 signaling | R-HSA-9020958 | 3.584929e-01 | 0.446 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 3.584929e-01 | 0.446 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 2.687685e-01 | 0.571 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 2.687685e-01 | 0.571 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.687685e-01 | 0.571 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 3.213894e-01 | 0.493 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 3.213894e-01 | 0.493 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 3.213894e-01 | 0.493 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 2.476290e-01 | 0.606 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 3.955650e-01 | 0.403 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 3.955650e-01 | 0.403 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 3.955650e-01 | 0.403 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 3.955650e-01 | 0.403 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 3.955650e-01 | 0.403 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 2.671613e-01 | 0.573 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 2.671613e-01 | 0.573 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 3.497763e-01 | 0.456 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 3.780276e-01 | 0.422 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 4.316195e-01 | 0.365 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 4.316195e-01 | 0.365 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 3.621251e-01 | 0.441 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 4.060101e-01 | 0.391 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 4.060101e-01 | 0.391 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 3.397977e-01 | 0.469 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 3.716883e-01 | 0.430 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 2.988219e-01 | 0.525 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 3.600142e-01 | 0.444 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 4.297091e-01 | 0.367 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 4.550922e-01 | 0.342 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 4.550922e-01 | 0.342 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 4.550922e-01 | 0.342 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 4.034556e-01 | 0.394 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 4.321639e-01 | 0.364 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.918356e-01 | 0.535 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.918356e-01 | 0.535 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 3.274349e-01 | 0.485 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 2.426792e-01 | 0.615 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 4.336064e-01 | 0.363 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 2.988219e-01 | 0.525 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 2.918356e-01 | 0.535 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 2.918356e-01 | 0.535 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 3.595542e-01 | 0.444 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 2.476290e-01 | 0.606 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 3.450313e-01 | 0.462 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 3.902497e-01 | 0.409 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 3.349594e-01 | 0.475 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 4.085345e-01 | 0.389 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 3.532881e-01 | 0.452 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 3.856090e-01 | 0.414 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 4.085345e-01 | 0.389 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 3.686825e-01 | 0.433 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 2.726330e-01 | 0.564 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 2.290097e-01 | 0.640 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 2.822190e-01 | 0.549 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 2.822190e-01 | 0.549 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 3.213894e-01 | 0.493 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 3.955650e-01 | 0.403 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 3.955650e-01 | 0.403 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 2.671613e-01 | 0.573 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 3.497763e-01 | 0.456 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 2.357633e-01 | 0.628 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 2.460499e-01 | 0.609 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 3.213894e-01 | 0.493 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 3.955650e-01 | 0.403 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 3.071301e-01 | 0.513 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 3.386093e-01 | 0.470 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 3.327212e-01 | 0.478 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 3.327212e-01 | 0.478 | 1 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 4.574935e-01 | 0.340 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 3.766049e-01 | 0.424 | 1 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 3.887876e-01 | 0.410 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 3.886595e-01 | 0.410 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 3.327212e-01 | 0.478 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 2.930163e-01 | 0.533 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 2.930163e-01 | 0.533 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 3.584929e-01 | 0.446 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 2.290097e-01 | 0.640 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 3.497763e-01 | 0.456 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 3.497763e-01 | 0.456 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 3.780276e-01 | 0.422 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 4.316195e-01 | 0.365 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 3.274349e-01 | 0.485 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 4.089801e-01 | 0.388 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 4.089801e-01 | 0.388 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 3.888795e-01 | 0.410 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 2.369905e-01 | 0.625 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 4.499270e-01 | 0.347 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 3.213894e-01 | 0.493 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 3.683693e-01 | 0.434 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 3.213894e-01 | 0.493 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 3.213601e-01 | 0.493 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 3.206189e-01 | 0.494 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 3.584929e-01 | 0.446 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 3.727713e-01 | 0.429 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 4.451777e-01 | 0.351 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 2.290097e-01 | 0.640 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 4.085345e-01 | 0.389 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 3.888795e-01 | 0.410 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 2.632520e-01 | 0.580 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 3.274349e-01 | 0.485 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 4.060101e-01 | 0.391 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 4.336064e-01 | 0.363 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 4.499270e-01 | 0.347 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 3.901174e-01 | 0.409 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 3.246726e-01 | 0.489 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 3.467480e-01 | 0.460 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 2.699857e-01 | 0.569 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 2.699857e-01 | 0.569 | 0 | 0 |
| Mitochondrial transcription initiation | R-HSA-163282 | 2.699857e-01 | 0.569 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 3.426911e-01 | 0.465 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 3.426911e-01 | 0.465 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 2.822190e-01 | 0.549 | 0 | 0 |
| Adenosine P1 receptors | R-HSA-417973 | 4.081594e-01 | 0.389 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 3.497763e-01 | 0.456 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 2.632520e-01 | 0.580 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 3.478683e-01 | 0.459 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 2.970919e-01 | 0.527 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 4.242423e-01 | 0.372 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 2.972000e-01 | 0.527 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 3.063297e-01 | 0.514 | 1 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 4.242423e-01 | 0.372 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 4.577107e-01 | 0.339 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 2.385563e-01 | 0.622 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 2.918356e-01 | 0.535 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 4.577107e-01 | 0.339 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 2.918356e-01 | 0.535 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 2.426792e-01 | 0.615 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 3.856090e-01 | 0.414 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 3.252655e-01 | 0.488 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 3.213894e-01 | 0.493 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 4.297091e-01 | 0.367 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 3.058098e-01 | 0.515 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 3.621251e-01 | 0.441 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 3.066356e-01 | 0.513 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 4.044814e-01 | 0.393 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 2.436399e-01 | 0.613 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 2.822190e-01 | 0.549 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 2.687685e-01 | 0.571 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 3.349594e-01 | 0.475 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 3.861900e-01 | 0.413 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 4.044814e-01 | 0.393 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 3.471684e-01 | 0.459 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 3.066356e-01 | 0.513 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 3.149421e-01 | 0.502 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 2.339845e-01 | 0.631 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 2.687685e-01 | 0.571 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 4.085345e-01 | 0.389 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 4.060101e-01 | 0.391 | 0 | 0 |
| Inhibition of membrane repair | R-HSA-9635644 | 2.699857e-01 | 0.569 | 0 | 0 |
| Transcription from mitochondrial promoters | R-HSA-75944 | 3.426911e-01 | 0.465 | 0 | 0 |
| Intracellular oxygen transport | R-HSA-8981607 | 4.081594e-01 | 0.389 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 3.955650e-01 | 0.403 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 3.683693e-01 | 0.434 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 4.336064e-01 | 0.363 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 3.192224e-01 | 0.496 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 3.252732e-01 | 0.488 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 4.089801e-01 | 0.388 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 4.089801e-01 | 0.388 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 3.592332e-01 | 0.445 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 3.592332e-01 | 0.445 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 3.592332e-01 | 0.445 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.460499e-01 | 0.609 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 3.955650e-01 | 0.403 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 2.808460e-01 | 0.552 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 4.316195e-01 | 0.365 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 4.321639e-01 | 0.364 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 2.986928e-01 | 0.525 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 3.162818e-01 | 0.500 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 3.274196e-01 | 0.485 | 0 | 0 |
| NTRK3 as a dependence receptor | R-HSA-9603505 | 2.699857e-01 | 0.569 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 2.436399e-01 | 0.613 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 2.822190e-01 | 0.549 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 3.206189e-01 | 0.494 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 3.151486e-01 | 0.501 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 4.366620e-01 | 0.360 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 2.387345e-01 | 0.622 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 3.645401e-01 | 0.438 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 2.687685e-01 | 0.571 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 4.021487e-01 | 0.396 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 2.870172e-01 | 0.542 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 3.584912e-01 | 0.446 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 3.206189e-01 | 0.494 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 4.550922e-01 | 0.342 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 4.550922e-01 | 0.342 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 3.584929e-01 | 0.446 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 2.452938e-01 | 0.610 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 4.089801e-01 | 0.388 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 4.034556e-01 | 0.394 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 3.584929e-01 | 0.446 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 2.339845e-01 | 0.631 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 3.745394e-01 | 0.427 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 3.601377e-01 | 0.444 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 4.336064e-01 | 0.363 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 4.607142e-01 | 0.337 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 4.607142e-01 | 0.337 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 4.607142e-01 | 0.337 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 4.633311e-01 | 0.334 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 4.664913e-01 | 0.331 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 4.664913e-01 | 0.331 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 4.664913e-01 | 0.331 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 4.664913e-01 | 0.331 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 4.664913e-01 | 0.331 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 4.664913e-01 | 0.331 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 4.664913e-01 | 0.331 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 4.664913e-01 | 0.331 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 4.671104e-01 | 0.331 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 4.671104e-01 | 0.331 | 0 | 0 |
| Extrinsic Pathway of Fibrin Clot Formation | R-HSA-140834 | 4.671104e-01 | 0.331 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 4.671104e-01 | 0.331 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 4.671104e-01 | 0.331 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 4.671104e-01 | 0.331 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 4.671104e-01 | 0.331 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 4.671104e-01 | 0.331 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 4.671104e-01 | 0.331 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 4.671104e-01 | 0.331 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 4.671104e-01 | 0.331 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 4.671104e-01 | 0.331 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 4.677293e-01 | 0.330 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 4.699518e-01 | 0.328 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 4.699518e-01 | 0.328 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 4.701211e-01 | 0.328 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 4.724203e-01 | 0.326 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 4.741034e-01 | 0.324 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 4.777034e-01 | 0.321 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 4.777034e-01 | 0.321 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 4.777034e-01 | 0.321 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 4.813274e-01 | 0.318 | 0 | 0 |
| Immune System | R-HSA-168256 | 4.831222e-01 | 0.316 | 1 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 4.897412e-01 | 0.310 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 4.897412e-01 | 0.310 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 4.909159e-01 | 0.309 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 4.910445e-01 | 0.309 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 4.999422e-01 | 0.301 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 4.999422e-01 | 0.301 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 4.999422e-01 | 0.301 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 5.000585e-01 | 0.301 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 5.000585e-01 | 0.301 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 5.000585e-01 | 0.301 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 5.000585e-01 | 0.301 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 5.000585e-01 | 0.301 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 5.000585e-01 | 0.301 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 5.000585e-01 | 0.301 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 5.000585e-01 | 0.301 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 5.000585e-01 | 0.301 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 5.028895e-01 | 0.299 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 5.068982e-01 | 0.295 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 5.068982e-01 | 0.295 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 5.068982e-01 | 0.295 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 5.131260e-01 | 0.290 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 5.131260e-01 | 0.290 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 5.131260e-01 | 0.290 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 5.131260e-01 | 0.290 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 5.201927e-01 | 0.284 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 5.201927e-01 | 0.284 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 5.201927e-01 | 0.284 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 5.201927e-01 | 0.284 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 5.201927e-01 | 0.284 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 5.201927e-01 | 0.284 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 5.201927e-01 | 0.284 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 5.201927e-01 | 0.284 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 5.201927e-01 | 0.284 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 5.201927e-01 | 0.284 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 5.202988e-01 | 0.284 | 1 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 5.284628e-01 | 0.277 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 5.284628e-01 | 0.277 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 5.284628e-01 | 0.277 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 5.322350e-01 | 0.274 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 5.322350e-01 | 0.274 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 5.322350e-01 | 0.274 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 5.322350e-01 | 0.274 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 5.322350e-01 | 0.274 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 5.322350e-01 | 0.274 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 5.322350e-01 | 0.274 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 5.322350e-01 | 0.274 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 5.340738e-01 | 0.272 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 5.340738e-01 | 0.272 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 5.382939e-01 | 0.269 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 5.382939e-01 | 0.269 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 5.382939e-01 | 0.269 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 5.382939e-01 | 0.269 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 5.431120e-01 | 0.265 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 5.432706e-01 | 0.265 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 5.473281e-01 | 0.262 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 5.473281e-01 | 0.262 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 5.473281e-01 | 0.262 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 5.473281e-01 | 0.262 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 5.473281e-01 | 0.262 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 5.495071e-01 | 0.260 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 5.546887e-01 | 0.256 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 5.579975e-01 | 0.253 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 5.611199e-01 | 0.251 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 5.626990e-01 | 0.250 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 5.626990e-01 | 0.250 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 5.626990e-01 | 0.250 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 5.626990e-01 | 0.250 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 5.626990e-01 | 0.250 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 5.626990e-01 | 0.250 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 5.629648e-01 | 0.250 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 5.629648e-01 | 0.250 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 5.629648e-01 | 0.250 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 5.629648e-01 | 0.250 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 5.629648e-01 | 0.250 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 5.639628e-01 | 0.249 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 5.658241e-01 | 0.247 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 5.669160e-01 | 0.246 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 5.669160e-01 | 0.246 | 1 | 1 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 5.679901e-01 | 0.246 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 5.679901e-01 | 0.246 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 5.679901e-01 | 0.246 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 5.679901e-01 | 0.246 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 5.679901e-01 | 0.246 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 5.679901e-01 | 0.246 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 5.679901e-01 | 0.246 | 0 | 0 |
| Defective CSF2RB causes SMDP5 | R-HSA-5688849 | 5.679901e-01 | 0.246 | 0 | 0 |
| Defective CSF2RA causes SMDP4 | R-HSA-5688890 | 5.679901e-01 | 0.246 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 5.679901e-01 | 0.246 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 5.679901e-01 | 0.246 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 5.679901e-01 | 0.246 | 0 | 0 |
| NGF-independant TRKA activation | R-HSA-187024 | 5.679901e-01 | 0.246 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 5.679901e-01 | 0.246 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 5.679901e-01 | 0.246 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 5.679901e-01 | 0.246 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 5.679901e-01 | 0.246 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 5.679901e-01 | 0.246 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 5.679901e-01 | 0.246 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 5.724252e-01 | 0.242 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 5.724252e-01 | 0.242 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 5.724252e-01 | 0.242 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 5.834309e-01 | 0.234 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 5.839258e-01 | 0.234 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 5.839258e-01 | 0.234 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 5.839258e-01 | 0.234 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 5.842799e-01 | 0.233 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 5.842799e-01 | 0.233 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 5.842799e-01 | 0.233 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 5.844187e-01 | 0.233 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 5.863016e-01 | 0.232 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 5.863016e-01 | 0.232 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 5.863016e-01 | 0.232 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 5.922169e-01 | 0.228 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 5.922169e-01 | 0.228 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 5.922169e-01 | 0.228 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 5.922169e-01 | 0.228 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 5.922169e-01 | 0.228 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 5.922169e-01 | 0.228 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 5.922169e-01 | 0.228 | 0 | 0 |
| Disease | R-HSA-1643685 | 5.943487e-01 | 0.226 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 6.005677e-01 | 0.221 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 6.005677e-01 | 0.221 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 6.040369e-01 | 0.219 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 6.040369e-01 | 0.219 | 1 | 1 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 6.040369e-01 | 0.219 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 6.044962e-01 | 0.219 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 6.090718e-01 | 0.215 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 6.110286e-01 | 0.214 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 6.110286e-01 | 0.214 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 6.110286e-01 | 0.214 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 6.110286e-01 | 0.214 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 6.110286e-01 | 0.214 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 6.110286e-01 | 0.214 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 6.110286e-01 | 0.214 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 6.110286e-01 | 0.214 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 6.110286e-01 | 0.214 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 6.110286e-01 | 0.214 | 0 | 0 |
| Lipid particle organization | R-HSA-8964572 | 6.110286e-01 | 0.214 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 6.110286e-01 | 0.214 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 6.188623e-01 | 0.208 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 6.188623e-01 | 0.208 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 6.188623e-01 | 0.208 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 6.199807e-01 | 0.208 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 6.199807e-01 | 0.208 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 6.199807e-01 | 0.208 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 6.199807e-01 | 0.208 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 6.199807e-01 | 0.208 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 6.199807e-01 | 0.208 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 6.199807e-01 | 0.208 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 6.199807e-01 | 0.208 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 6.232122e-01 | 0.205 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 6.232122e-01 | 0.205 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 6.232122e-01 | 0.205 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 6.264068e-01 | 0.203 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 6.278450e-01 | 0.202 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 6.309884e-01 | 0.200 | 1 | 1 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 6.309884e-01 | 0.200 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 6.356625e-01 | 0.197 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 6.356625e-01 | 0.197 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 6.356625e-01 | 0.197 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 6.377947e-01 | 0.195 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 6.394725e-01 | 0.194 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 6.410718e-01 | 0.193 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 6.417887e-01 | 0.193 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 6.462623e-01 | 0.190 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 6.462623e-01 | 0.190 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 6.462623e-01 | 0.190 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 6.462623e-01 | 0.190 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 6.462623e-01 | 0.190 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 6.462623e-01 | 0.190 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 6.462623e-01 | 0.190 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 6.462623e-01 | 0.190 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 6.462623e-01 | 0.190 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 6.467984e-01 | 0.189 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 6.474775e-01 | 0.189 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 6.497817e-01 | 0.187 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 6.497817e-01 | 0.187 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 6.497817e-01 | 0.187 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 6.497817e-01 | 0.187 | 0 | 0 |
| DAG1 core M1 glycosylations | R-HSA-8932506 | 6.497817e-01 | 0.187 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 6.497817e-01 | 0.187 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 6.497817e-01 | 0.187 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis | R-HSA-9632974 | 6.497817e-01 | 0.187 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 6.497817e-01 | 0.187 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 6.497817e-01 | 0.187 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 6.497817e-01 | 0.187 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 6.497817e-01 | 0.187 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 6.497817e-01 | 0.187 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 6.497817e-01 | 0.187 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 6.497817e-01 | 0.187 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 6.497817e-01 | 0.187 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 6.497817e-01 | 0.187 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 6.497817e-01 | 0.187 | 0 | 0 |
| Activation of TRKA receptors | R-HSA-187015 | 6.497817e-01 | 0.187 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 6.497817e-01 | 0.187 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 6.497817e-01 | 0.187 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 6.497817e-01 | 0.187 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 6.517592e-01 | 0.186 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 6.519991e-01 | 0.186 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 6.520379e-01 | 0.186 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 6.520379e-01 | 0.186 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 6.535157e-01 | 0.185 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 6.568995e-01 | 0.183 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 6.597537e-01 | 0.181 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 6.597537e-01 | 0.181 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 6.597537e-01 | 0.181 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 6.597537e-01 | 0.181 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 6.678617e-01 | 0.175 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 6.710815e-01 | 0.173 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 6.722137e-01 | 0.172 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 6.756682e-01 | 0.170 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 6.756682e-01 | 0.170 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 6.756682e-01 | 0.170 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 6.766263e-01 | 0.170 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 6.770984e-01 | 0.169 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 6.832424e-01 | 0.165 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 6.837942e-01 | 0.165 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 6.839571e-01 | 0.165 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 6.846759e-01 | 0.165 | 0 | 0 |
| DAG1 core M2 glycosylations | R-HSA-8932504 | 6.846759e-01 | 0.165 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 6.846759e-01 | 0.165 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 6.846759e-01 | 0.165 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 6.846759e-01 | 0.165 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 6.846759e-01 | 0.165 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 6.846759e-01 | 0.165 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 6.846759e-01 | 0.165 | 0 | 0 |
| Fructose biosynthesis | R-HSA-5652227 | 6.846759e-01 | 0.165 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 6.846759e-01 | 0.165 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 6.846759e-01 | 0.165 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 6.846759e-01 | 0.165 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 6.846759e-01 | 0.165 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 6.847790e-01 | 0.164 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 6.898077e-01 | 0.161 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 6.898077e-01 | 0.161 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 6.912154e-01 | 0.160 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 6.915153e-01 | 0.160 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 6.915153e-01 | 0.160 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 6.931468e-01 | 0.159 | 1 | 1 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 6.938175e-01 | 0.159 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 6.944688e-01 | 0.158 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 6.944688e-01 | 0.158 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 6.944688e-01 | 0.158 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 6.944688e-01 | 0.158 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 6.944688e-01 | 0.158 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 6.973625e-01 | 0.157 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 7.010833e-01 | 0.154 | 0 | 0 |
| Translation | R-HSA-72766 | 7.018323e-01 | 0.154 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 7.033192e-01 | 0.153 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 7.099476e-01 | 0.149 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 7.099476e-01 | 0.149 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 7.099476e-01 | 0.149 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 7.099476e-01 | 0.149 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 7.099476e-01 | 0.149 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 7.160953e-01 | 0.145 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 7.160953e-01 | 0.145 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 7.160953e-01 | 0.145 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 7.160953e-01 | 0.145 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 7.160953e-01 | 0.145 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 7.160953e-01 | 0.145 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 7.160953e-01 | 0.145 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 7.160953e-01 | 0.145 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 7.160953e-01 | 0.145 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 7.160953e-01 | 0.145 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 7.160953e-01 | 0.145 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 7.160953e-01 | 0.145 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 7.160953e-01 | 0.145 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 7.160953e-01 | 0.145 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 7.164630e-01 | 0.145 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 7.164630e-01 | 0.145 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 7.164630e-01 | 0.145 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 7.164630e-01 | 0.145 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 7.164630e-01 | 0.145 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 7.164630e-01 | 0.145 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 7.164630e-01 | 0.145 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 7.253741e-01 | 0.139 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 7.253741e-01 | 0.139 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 7.253741e-01 | 0.139 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 7.253741e-01 | 0.139 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 7.253741e-01 | 0.139 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 7.253741e-01 | 0.139 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 7.264490e-01 | 0.139 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 7.275201e-01 | 0.138 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 7.275201e-01 | 0.138 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 7.275201e-01 | 0.138 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 7.275201e-01 | 0.138 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 7.291297e-01 | 0.137 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 7.313675e-01 | 0.136 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 7.371096e-01 | 0.132 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 7.371096e-01 | 0.132 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 7.371096e-01 | 0.132 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 7.371096e-01 | 0.132 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 7.371096e-01 | 0.132 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 7.371096e-01 | 0.132 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 7.371096e-01 | 0.132 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 7.442461e-01 | 0.128 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 7.443857e-01 | 0.128 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 7.443857e-01 | 0.128 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 7.443857e-01 | 0.128 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 7.443857e-01 | 0.128 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 7.443857e-01 | 0.128 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 7.443857e-01 | 0.128 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 7.443857e-01 | 0.128 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 7.443857e-01 | 0.128 | 0 | 0 |
| Sperm Motility And Taxes | R-HSA-1300642 | 7.443857e-01 | 0.128 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 7.443857e-01 | 0.128 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 7.443857e-01 | 0.128 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 7.443857e-01 | 0.128 | 0 | 0 |
| Serotonin receptors | R-HSA-390666 | 7.443857e-01 | 0.128 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 7.443857e-01 | 0.128 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 7.533169e-01 | 0.123 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 7.544419e-01 | 0.122 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 7.564587e-01 | 0.121 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 7.564587e-01 | 0.121 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 7.639295e-01 | 0.117 | 1 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 7.648039e-01 | 0.116 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 7.652409e-01 | 0.116 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 7.657782e-01 | 0.116 | 0 | 0 |
| DAG1 core M3 glycosylations | R-HSA-8932505 | 7.698585e-01 | 0.114 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 7.698585e-01 | 0.114 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 7.698585e-01 | 0.114 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 7.698585e-01 | 0.114 | 0 | 0 |
| Conjugation of benzoate with glycine | R-HSA-177135 | 7.698585e-01 | 0.114 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 7.698585e-01 | 0.114 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 7.698585e-01 | 0.114 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 7.698585e-01 | 0.114 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 7.698585e-01 | 0.114 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 7.698585e-01 | 0.114 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 7.698585e-01 | 0.114 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 7.698585e-01 | 0.114 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 7.698585e-01 | 0.114 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 7.745637e-01 | 0.111 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 7.745637e-01 | 0.111 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 7.745637e-01 | 0.111 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 7.745637e-01 | 0.111 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 7.745637e-01 | 0.111 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 7.752288e-01 | 0.111 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 7.752288e-01 | 0.111 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 7.772039e-01 | 0.109 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 7.861282e-01 | 0.105 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 7.886925e-01 | 0.103 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 7.886925e-01 | 0.103 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 7.895269e-01 | 0.103 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 7.914804e-01 | 0.102 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 7.914804e-01 | 0.102 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 7.914804e-01 | 0.102 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 7.927942e-01 | 0.101 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 7.927942e-01 | 0.101 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 7.927942e-01 | 0.101 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 7.927942e-01 | 0.101 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 7.957940e-01 | 0.099 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 7.957940e-01 | 0.099 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 7.997142e-01 | 0.097 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 7.997142e-01 | 0.097 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 8.030604e-01 | 0.095 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 8.030604e-01 | 0.095 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 8.053656e-01 | 0.094 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 8.072659e-01 | 0.093 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 8.072659e-01 | 0.093 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 8.072659e-01 | 0.093 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 8.072659e-01 | 0.093 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 8.112794e-01 | 0.091 | 0 | 0 |
| Defective EXT1 causes exostoses 1, TRPS2 and CHDS | R-HSA-3656253 | 8.134453e-01 | 0.090 | 0 | 0 |
| Defective EXT2 causes exostoses 2 | R-HSA-3656237 | 8.134453e-01 | 0.090 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 8.134453e-01 | 0.090 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 8.134453e-01 | 0.090 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 8.134453e-01 | 0.090 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 8.134453e-01 | 0.090 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.134453e-01 | 0.090 | 0 | 0 |
| Conjugation of salicylate with glycine | R-HSA-177128 | 8.134453e-01 | 0.090 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 8.134453e-01 | 0.090 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 8.134453e-01 | 0.090 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 8.134453e-01 | 0.090 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 8.141259e-01 | 0.089 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 8.158547e-01 | 0.088 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 8.158547e-01 | 0.088 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 8.166629e-01 | 0.088 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 8.203915e-01 | 0.086 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 8.219774e-01 | 0.085 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 8.219774e-01 | 0.085 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 8.219774e-01 | 0.085 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 8.219774e-01 | 0.085 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 8.274154e-01 | 0.082 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 8.279359e-01 | 0.082 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 8.286429e-01 | 0.082 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 8.298883e-01 | 0.081 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 8.300664e-01 | 0.081 | 0 | 0 |
| PDH complex synthesizes acetyl-CoA from PYR | R-HSA-9861559 | 8.320394e-01 | 0.080 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 8.320394e-01 | 0.080 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 8.320394e-01 | 0.080 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 8.320394e-01 | 0.080 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 8.320394e-01 | 0.080 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 8.320394e-01 | 0.080 | 0 | 0 |
| rRNA modification in the mitochondrion | R-HSA-6793080 | 8.320394e-01 | 0.080 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 8.320394e-01 | 0.080 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 8.320394e-01 | 0.080 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 8.320394e-01 | 0.080 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 8.342515e-01 | 0.079 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 8.342515e-01 | 0.079 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 8.356723e-01 | 0.078 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 8.356723e-01 | 0.078 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 8.356723e-01 | 0.078 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 8.356723e-01 | 0.078 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 8.356723e-01 | 0.078 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 8.393311e-01 | 0.076 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 8.393311e-01 | 0.076 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 8.426524e-01 | 0.074 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 8.473500e-01 | 0.072 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 8.481416e-01 | 0.072 | 1 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 8.481416e-01 | 0.072 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 8.484069e-01 | 0.071 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 8.484069e-01 | 0.071 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 8.484069e-01 | 0.071 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 8.484069e-01 | 0.071 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 8.484069e-01 | 0.071 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 8.484069e-01 | 0.071 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 8.484069e-01 | 0.071 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 8.487812e-01 | 0.071 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 8.487812e-01 | 0.071 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 8.487812e-01 | 0.071 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 8.487812e-01 | 0.071 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 8.487812e-01 | 0.071 | 0 | 0 |
| Beta oxidation of hexanoyl-CoA to butanoyl-CoA | R-HSA-77350 | 8.487812e-01 | 0.071 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 8.487812e-01 | 0.071 | 0 | 0 |
| Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA | R-HSA-77310 | 8.487812e-01 | 0.071 | 0 | 0 |
| Beta oxidation of octanoyl-CoA to hexanoyl-CoA | R-HSA-77348 | 8.487812e-01 | 0.071 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 8.487812e-01 | 0.071 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 8.487812e-01 | 0.071 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.487812e-01 | 0.071 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 8.487812e-01 | 0.071 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 8.487812e-01 | 0.071 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 8.487812e-01 | 0.071 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 8.487812e-01 | 0.071 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 8.499490e-01 | 0.071 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 8.565400e-01 | 0.067 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 8.565647e-01 | 0.067 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 8.565647e-01 | 0.067 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 8.565656e-01 | 0.067 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 8.565656e-01 | 0.067 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 8.601738e-01 | 0.065 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 8.601738e-01 | 0.065 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 8.602366e-01 | 0.065 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 8.602366e-01 | 0.065 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 8.602366e-01 | 0.065 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 8.602366e-01 | 0.065 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 8.638550e-01 | 0.064 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 8.638550e-01 | 0.064 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 8.638550e-01 | 0.064 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 8.638550e-01 | 0.064 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 8.638550e-01 | 0.064 | 0 | 0 |
| Beta oxidation of butanoyl-CoA to acetyl-CoA | R-HSA-77352 | 8.638550e-01 | 0.064 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 8.638550e-01 | 0.064 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 8.638550e-01 | 0.064 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 8.638550e-01 | 0.064 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 8.638550e-01 | 0.064 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 8.638550e-01 | 0.064 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 8.645940e-01 | 0.063 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 8.696768e-01 | 0.061 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 8.712152e-01 | 0.060 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 8.712152e-01 | 0.060 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 8.712152e-01 | 0.060 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 8.712152e-01 | 0.060 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 8.722416e-01 | 0.059 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 8.722416e-01 | 0.059 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 8.735796e-01 | 0.059 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 8.735796e-01 | 0.059 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 8.759617e-01 | 0.058 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 8.774271e-01 | 0.057 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 8.774271e-01 | 0.057 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 8.774271e-01 | 0.057 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 8.774271e-01 | 0.057 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 8.774271e-01 | 0.057 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 8.774271e-01 | 0.057 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 8.774271e-01 | 0.057 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 8.774271e-01 | 0.057 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 8.774271e-01 | 0.057 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 8.774271e-01 | 0.057 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 8.774271e-01 | 0.057 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 8.774271e-01 | 0.057 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 8.774271e-01 | 0.057 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 8.786045e-01 | 0.056 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 8.786045e-01 | 0.056 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 8.795200e-01 | 0.056 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 8.813948e-01 | 0.055 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 8.813948e-01 | 0.055 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 8.814131e-01 | 0.055 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 8.814131e-01 | 0.055 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 8.861840e-01 | 0.052 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 8.869844e-01 | 0.052 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 8.869844e-01 | 0.052 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 8.896470e-01 | 0.051 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 8.896470e-01 | 0.051 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 8.896470e-01 | 0.051 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 8.896470e-01 | 0.051 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 8.896470e-01 | 0.051 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 8.896470e-01 | 0.051 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 8.896470e-01 | 0.051 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 8.896470e-01 | 0.051 | 0 | 0 |
| Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA | R-HSA-77346 | 8.896470e-01 | 0.051 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 8.896470e-01 | 0.051 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 8.896470e-01 | 0.051 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 8.902832e-01 | 0.050 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 8.930192e-01 | 0.049 | 1 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 8.937280e-01 | 0.049 | 1 | 0 |
| Ca-dependent events | R-HSA-111996 | 8.948431e-01 | 0.048 | 1 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 8.995555e-01 | 0.046 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 8.995555e-01 | 0.046 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 8.995555e-01 | 0.046 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 8.995555e-01 | 0.046 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 8.995555e-01 | 0.046 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 8.995555e-01 | 0.046 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 9.006492e-01 | 0.045 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 9.006492e-01 | 0.045 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 9.006492e-01 | 0.045 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 9.006492e-01 | 0.045 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 9.006492e-01 | 0.045 | 0 | 0 |
| Sulfide oxidation to sulfate | R-HSA-1614517 | 9.006492e-01 | 0.045 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 9.006492e-01 | 0.045 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 9.006492e-01 | 0.045 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 9.006492e-01 | 0.045 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.048705e-01 | 0.043 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 9.076307e-01 | 0.042 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 9.079216e-01 | 0.042 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 9.086664e-01 | 0.042 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.086664e-01 | 0.042 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.091022e-01 | 0.041 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 9.105551e-01 | 0.041 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 9.105551e-01 | 0.041 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 9.105551e-01 | 0.041 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 9.105551e-01 | 0.041 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 9.105551e-01 | 0.041 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 9.105551e-01 | 0.041 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 9.105551e-01 | 0.041 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 9.105551e-01 | 0.041 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 9.108122e-01 | 0.041 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.136272e-01 | 0.039 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.147128e-01 | 0.039 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 9.150948e-01 | 0.039 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 9.150948e-01 | 0.039 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.150948e-01 | 0.039 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 9.155531e-01 | 0.038 | 1 | 1 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 9.155531e-01 | 0.038 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 9.155531e-01 | 0.038 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 9.182165e-01 | 0.037 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 9.194738e-01 | 0.036 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 9.194738e-01 | 0.036 | 0 | 0 |
| Conjugation of carboxylic acids | R-HSA-159424 | 9.194738e-01 | 0.036 | 0 | 0 |
| Amino Acid conjugation | R-HSA-156587 | 9.194738e-01 | 0.036 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 9.194738e-01 | 0.036 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 9.194738e-01 | 0.036 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 9.194738e-01 | 0.036 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 9.194738e-01 | 0.036 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 9.194738e-01 | 0.036 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.200844e-01 | 0.036 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.200844e-01 | 0.036 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 9.215841e-01 | 0.035 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.219894e-01 | 0.035 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.219894e-01 | 0.035 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 9.225932e-01 | 0.035 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 9.251812e-01 | 0.034 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.252992e-01 | 0.034 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.252992e-01 | 0.034 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 9.272186e-01 | 0.033 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 9.275037e-01 | 0.033 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 9.275037e-01 | 0.033 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 9.275037e-01 | 0.033 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.275037e-01 | 0.033 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 9.275037e-01 | 0.033 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.275037e-01 | 0.033 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.275165e-01 | 0.033 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.279801e-01 | 0.032 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.283538e-01 | 0.032 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.283538e-01 | 0.032 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.283538e-01 | 0.032 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.283538e-01 | 0.032 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.283538e-01 | 0.032 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 9.283538e-01 | 0.032 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.304693e-01 | 0.031 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.330492e-01 | 0.030 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.338728e-01 | 0.030 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.338728e-01 | 0.030 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.342252e-01 | 0.030 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 9.342252e-01 | 0.030 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 9.347333e-01 | 0.029 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 9.347333e-01 | 0.029 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.347333e-01 | 0.029 | 0 | 0 |
| Vitamin C (ascorbate) metabolism | R-HSA-196836 | 9.347333e-01 | 0.029 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.347333e-01 | 0.029 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 9.347333e-01 | 0.029 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 9.373871e-01 | 0.028 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 9.373871e-01 | 0.028 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.373871e-01 | 0.028 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.373871e-01 | 0.028 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.396385e-01 | 0.027 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 9.396385e-01 | 0.027 | 1 | 1 |
| CaM pathway | R-HSA-111997 | 9.396385e-01 | 0.027 | 1 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.396385e-01 | 0.027 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.396385e-01 | 0.027 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 9.412423e-01 | 0.026 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.419635e-01 | 0.026 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.423867e-01 | 0.026 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.446268e-01 | 0.025 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 9.462279e-01 | 0.024 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.462279e-01 | 0.024 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 9.471026e-01 | 0.024 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 9.471026e-01 | 0.024 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.471026e-01 | 0.024 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 9.471026e-01 | 0.024 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.471026e-01 | 0.024 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.471026e-01 | 0.024 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.492208e-01 | 0.023 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.501993e-01 | 0.022 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.523786e-01 | 0.021 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.523786e-01 | 0.021 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 9.523786e-01 | 0.021 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.523786e-01 | 0.021 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 9.523786e-01 | 0.021 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 9.523786e-01 | 0.021 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 9.523786e-01 | 0.021 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 9.534497e-01 | 0.021 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.534497e-01 | 0.021 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.534497e-01 | 0.021 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.536073e-01 | 0.021 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.538957e-01 | 0.020 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.539887e-01 | 0.020 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.541630e-01 | 0.020 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.541630e-01 | 0.020 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.556152e-01 | 0.020 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.562651e-01 | 0.019 | 0 | 0 |
| CYP2E1 reactions | R-HSA-211999 | 9.571287e-01 | 0.019 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 9.571287e-01 | 0.019 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.571287e-01 | 0.019 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.571287e-01 | 0.019 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.573405e-01 | 0.019 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.583441e-01 | 0.018 | 1 | 1 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.597616e-01 | 0.018 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.605313e-01 | 0.017 | 1 | 1 |
| Paracetamol ADME | R-HSA-9753281 | 9.605313e-01 | 0.017 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.609186e-01 | 0.017 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.609186e-01 | 0.017 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.614053e-01 | 0.017 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.614053e-01 | 0.017 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.614053e-01 | 0.017 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.614053e-01 | 0.017 | 0 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 9.614053e-01 | 0.017 | 0 | 0 |
| Fertilization | R-HSA-1187000 | 9.614053e-01 | 0.017 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.614053e-01 | 0.017 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 9.628433e-01 | 0.016 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.634099e-01 | 0.016 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.642077e-01 | 0.016 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.642077e-01 | 0.016 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.642077e-01 | 0.016 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.642077e-01 | 0.016 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 9.652555e-01 | 0.015 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.652555e-01 | 0.015 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 9.652555e-01 | 0.015 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 9.654243e-01 | 0.015 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.662615e-01 | 0.015 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 9.672297e-01 | 0.014 | 0 | 0 |
| Cobalamin (Cbl) metabolism | R-HSA-9759218 | 9.687217e-01 | 0.014 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 9.687217e-01 | 0.014 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.687217e-01 | 0.014 | 0 | 0 |
| Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane | R-HSA-83936 | 9.687217e-01 | 0.014 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 9.687217e-01 | 0.014 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.687217e-01 | 0.014 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.700052e-01 | 0.013 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 9.700931e-01 | 0.013 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.705774e-01 | 0.013 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.714930e-01 | 0.013 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.714930e-01 | 0.013 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.718424e-01 | 0.012 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 9.718424e-01 | 0.012 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.718424e-01 | 0.012 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.725533e-01 | 0.012 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.746109e-01 | 0.011 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 9.746519e-01 | 0.011 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.748917e-01 | 0.011 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.748917e-01 | 0.011 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 9.748917e-01 | 0.011 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.748917e-01 | 0.011 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.749561e-01 | 0.011 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.754483e-01 | 0.011 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.759086e-01 | 0.011 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.770370e-01 | 0.010 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.770370e-01 | 0.010 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.770370e-01 | 0.010 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.771812e-01 | 0.010 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.771812e-01 | 0.010 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.771812e-01 | 0.010 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.771812e-01 | 0.010 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.773422e-01 | 0.010 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.773422e-01 | 0.010 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.775204e-01 | 0.010 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.777162e-01 | 0.010 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.790042e-01 | 0.009 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.808021e-01 | 0.008 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.808077e-01 | 0.008 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 9.815082e-01 | 0.008 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.815082e-01 | 0.008 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 9.815082e-01 | 0.008 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.841734e-01 | 0.007 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.850151e-01 | 0.007 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.850151e-01 | 0.007 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.853614e-01 | 0.006 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.853614e-01 | 0.006 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.865108e-01 | 0.006 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.865108e-01 | 0.006 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.865108e-01 | 0.006 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 9.865108e-01 | 0.006 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 9.866311e-01 | 0.006 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.877932e-01 | 0.005 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.878572e-01 | 0.005 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.878572e-01 | 0.005 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.878572e-01 | 0.005 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.882045e-01 | 0.005 | 0 | 0 |
| HS-GAG biosynthesis | R-HSA-2022928 | 9.890694e-01 | 0.005 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.890694e-01 | 0.005 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.890694e-01 | 0.005 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.891420e-01 | 0.005 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.895492e-01 | 0.005 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.896209e-01 | 0.005 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.900076e-01 | 0.004 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.901606e-01 | 0.004 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.901606e-01 | 0.004 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.901606e-01 | 0.004 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.901606e-01 | 0.004 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.902797e-01 | 0.004 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.908065e-01 | 0.004 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.911429e-01 | 0.004 | 0 | 0 |
| tRNA processing in the mitochondrion | R-HSA-6785470 | 9.911429e-01 | 0.004 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.911429e-01 | 0.004 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.914877e-01 | 0.004 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.920272e-01 | 0.003 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.921862e-01 | 0.003 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.923396e-01 | 0.003 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.925982e-01 | 0.003 | 1 | 1 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.928233e-01 | 0.003 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.928233e-01 | 0.003 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.929561e-01 | 0.003 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.929561e-01 | 0.003 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 9.935399e-01 | 0.003 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.935399e-01 | 0.003 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.935770e-01 | 0.003 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.939475e-01 | 0.003 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.939475e-01 | 0.003 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.939604e-01 | 0.003 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.941443e-01 | 0.003 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.941443e-01 | 0.003 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.944485e-01 | 0.002 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.947657e-01 | 0.002 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.947657e-01 | 0.002 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.947657e-01 | 0.002 | 0 | 0 |
| Pyrimidine catabolism | R-HSA-73621 | 9.952885e-01 | 0.002 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.955671e-01 | 0.002 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.957590e-01 | 0.002 | 0 | 0 |
| Methylation | R-HSA-156581 | 9.957590e-01 | 0.002 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.957590e-01 | 0.002 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.961826e-01 | 0.002 | 0 | 0 |
| mitochondrial fatty acid beta-oxidation of saturated fatty acids | R-HSA-77286 | 9.961826e-01 | 0.002 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.961826e-01 | 0.002 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 9.961826e-01 | 0.002 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.961826e-01 | 0.002 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.961826e-01 | 0.002 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.966490e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.966490e-01 | 0.001 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.969483e-01 | 0.001 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.974347e-01 | 0.001 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.974490e-01 | 0.001 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.974702e-01 | 0.001 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.974702e-01 | 0.001 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.975232e-01 | 0.001 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.976971e-01 | 0.001 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.976971e-01 | 0.001 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.977446e-01 | 0.001 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.978441e-01 | 0.001 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.979700e-01 | 0.001 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.984458e-01 | 0.001 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.985530e-01 | 0.001 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.986068e-01 | 0.001 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.987240e-01 | 0.001 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.988009e-01 | 0.001 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.988115e-01 | 0.001 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.988115e-01 | 0.001 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.988736e-01 | 0.000 | 1 | 0 |
| Protein localization | R-HSA-9609507 | 9.989562e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.990206e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.990314e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.990421e-01 | 0.000 | 1 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.991065e-01 | 0.000 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 9.991257e-01 | 0.000 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.992131e-01 | 0.000 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.992131e-01 | 0.000 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.992131e-01 | 0.000 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.992131e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.992493e-01 | 0.000 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.992918e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.993685e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.994837e-01 | 0.000 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.995844e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.996236e-01 | 0.000 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.996236e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.996366e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.996613e-01 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.997154e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.997441e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.997531e-01 | 0.000 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.997531e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.997828e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.997828e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.998000e-01 | 0.000 | 0 | 0 |
| Transport of vitamins, nucleosides, and related molecules | R-HSA-425397 | 9.998200e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.998234e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.998304e-01 | 0.000 | 1 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.998380e-01 | 0.000 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.998380e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.998820e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.999140e-01 | 0.000 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.999303e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999357e-01 | 0.000 | 1 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.999543e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999668e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999700e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.999765e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999787e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999791e-01 | 0.000 | 1 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.999841e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999850e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999871e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999896e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.999916e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999939e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999941e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 9.999951e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999970e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999971e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999977e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999985e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999987e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.999990e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999992e-01 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 9.999992e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999996e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999997e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999998e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999999e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999999e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999999e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999999e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.999999e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |